<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Harm Reduct J</journal-id><journal-id journal-id-type="iso-abbrev">Harm Reduct J</journal-id><journal-id journal-id-type="pmc-domain-id">242</journal-id><journal-id journal-id-type="pmc-domain">harmred</journal-id><journal-title-group><journal-title>Harm Reduction Journal</journal-title></journal-title-group><issn pub-type="epub">1477-7517</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10044112</article-id><article-id pub-id-type="pmcid-ver">PMC10044112.2</article-id><article-id pub-id-type="pmcaid">10044112</article-id><article-id pub-id-type="pmcaiid">10052837</article-id><article-id pub-id-type="pmid">36978089</article-id><article-id pub-id-type="doi">10.1186/s12954-023-00773-2</article-id><article-id pub-id-type="publisher-id">773</article-id><article-version article-version-type="pmc-version">2</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Curtis</surname><given-names initials="M">Michael</given-names></name><address><email>michael.curtis@burnet.edu.au</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilkinson</surname><given-names initials="AL">Anna L.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dietze</surname><given-names initials="P">Paul</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stewart</surname><given-names initials="AC">Ashleigh C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kinner</surname><given-names initials="SA">Stuart A.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Winter</surname><given-names initials="RJ">Rebecca J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aitken</surname><given-names initials="C">Campbell</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Walker</surname><given-names initials="SJ">Shelley J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cossar</surname><given-names initials="RD">Reece D.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Butler</surname><given-names initials="T">Tony</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stoov&#233;</surname><given-names initials="M">Mark</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.1056.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2224 8486</institution-id><institution>Disease Elimination Program, Public Health Discipline, </institution><institution>Burnet Institute, </institution></institution-wrap>85 Commercial Road, Melbourne, VIC 3004 Australia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.1002.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7857</institution-id><institution>School of Public Health and Preventive Medicine, </institution><institution>Monash University, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.1002.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7857</institution-id><institution>Monash Addition Research Centre, </institution><institution>Monash University, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.1032.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0375 4078</institution-id><institution>National Drug Research Institute, </institution><institution>Curtin University, </institution></institution-wrap>Melbourne, Australia </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.1032.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0375 4078</institution-id><institution>School of Population Health, </institution><institution>Curtin University, </institution></institution-wrap>Perth, WA Australia </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Justice Health Unit, Melbourne School of Population and Global Health, </institution><institution>University of Melbourne, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Centre for Adolescent Health, </institution><institution>Murdoch Children&#8217;s Research Institute, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.1022.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0437 5432</institution-id><institution>Griffith Criminology Institute, </institution><institution>Griffith University, </institution></institution-wrap>Brisbane, QLD Australia </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.413105.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 8606 2560</institution-id><institution>Department of Gastroenterology, </institution><institution>St Vincent&#8217;s Hospital, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.1005.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4902 0432</institution-id><institution>School of Population Health, </institution><institution>University of New South Wales, </institution></institution-wrap>Sydney, NSW Australia </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.1018.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2342 0938</institution-id><institution>School of Psychology and Public Health, </institution><institution>La Trobe University, </institution></institution-wrap>Melbourne, Australia </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>20</volume><issue-id pub-id-type="pmc-issue-id">425656</issue-id><elocation-id>42</elocation-id><history><date date-type="received"><day>11</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>03</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>28</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-03-30 00:10:20.470"><day>30</day><month>03</month><year>2023</year></date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10044112</article-id><article-id pub-id-type="doi">10.1186/s12954-023-00773-2</article-id><article-version>1</article-version><pub-date><day>28</day><month>03</month><year>2023</year></pub-date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10052837</article-id><article-id pub-id-type="doi">10.1186/s12954-023-00773-2</article-id><article-version>2</article-version><pub-date><day>28</day><month>03</month><year>2023</year></pub-date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12954_2023_Article_773.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">A precipitous decline in health status among people recently released from prison is common. In Victoria, Australia, opioid agonist treatment (OAT) in the community involves frequent contact with primary care, potentially facilitating broader use of primary healthcare services. Among a cohort of men who injected drugs regularly pre-imprisonment, we estimated differences in rates of primary healthcare use and medication dispensation between people who did and did not receive OAT post-release.
</p></sec><sec><title>Methods</title><p id="Par2">Data came from the Prison and Transition Health Cohort Study. Three-month post-release follow-up interviews were linked with primary care and medication dispensation records. Generalised linear models were fit with one exposure (OAT: none/partial/complete) for 13 outcomes relating to primary healthcare use, pathology testing, and medication dispensation, adjusted for other covariates. Coefficients were reported as adjusted incidence rate ratios (AIRR).
</p></sec><sec><title>Results</title><p id="Par3">Analyses included 255 participants. Compared to no OAT use, both partial and complete OAT use were associated with increased rates of standard (AIRR: 3.02, 95%CI: 1.88&#8211;4.86; AIRR: 3.66, 95%CI: 2.57&#8211;5.23), extended (AIRR: 2.56, 95%CI: 1.41&#8211;4.67; AIRR: 2.55, 95%CI: 1.60&#8211;4.07) and mental health-related (AIRR: 2.71, 95%CI: 1.42&#8211;5.20; AIRR: 2.27, 95%CI: 1.33&#8211;3.87) general practitioner (GP) consultations, total medication (AIRR: 1.88, 95%CI: 1.19&#8211;2.98; AIRR: 2.40, 95%CI: 1.71&#8211;3.37), benzodiazepine (AIRR: 4.99, 95%CI: 2.81&#8211;8.85; AIRR: 8.30, 95%CI: 5.28&#8211;13.04) and gabapentinoid (AIRR: 6.78, 95%CI: 3.34&#8211;13.77; AIRR: 4.34, 95%CI: 2.37&#8211;7.94) dispensations, respectively. Partial OAT use was also associated with increased after-hours GP consultations (AIRR: 4.61, 95%CI: 2.24&#8211;9.48) and complete OAT use? with increased pathology utilisation (e.g. haematological, chemical, microbiological or immunological tissue/sample testing; AIRR: 2.30, 95%CI: 1.52&#8211;3.48).</p></sec><sec><title>Conclusion</title><p id="Par4">We observed higher rates of primary healthcare use and medication dispensation among people who reported partial and complete OAT use post-release. Findings suggest that access to OAT post-release may have a collateral benefit in supporting broader health service utilisation, underscoring the importance of retention in OAT after release from prison.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Injecting drug use</kwd><kwd>Prison</kwd><kwd>Opioids</kwd><kwd>Opioid agonist treatment</kwd><kwd>Harm reduction</kwd><kwd>Methadone</kwd><kwd>Buprenorphine</kwd><kwd>Primary care</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>APP1168954</award-id><principal-award-recipient><name name-style="western"><surname>Curtis</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par5">People in prison experience poorer physical and mental health than people in the general population [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Conditions such as cardiovascular disease, blood borne viruses, substance use disorders and mental illness are all more prevalent among people in prison than the general population [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref>]. Difficulties with obtaining secure housing [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], re-establishing social support networks [<xref ref-type="bibr" rid="CR9">9</xref>], substance use [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>] and unemployment [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>] are common following community re-entry. These challenges often intersect and compound disadvantage [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], contributing to declines in physical and mental health [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] and increased risk of mortality [<xref ref-type="bibr" rid="CR19">19</xref>&#8211;<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par6">Early and regular contact with primary care has the potential to support improved physical and mental health among people recently released from prison [<xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR25">25</xref>]. For people experiencing opioid dependence, one mechanism likely to promote early and regular primary healthcare contact after release from prison is use of primary healthcare-based opioid agonist treatment (OAT). In some Australian jurisdictions, programmes that include short-term subsidisation of OAT dispensing fees, to support continuity of prison-based OAT in the community, require people continuing OAT post-release to present to a primary healthcare-based general practitioner (GP) within one week of release [<xref ref-type="bibr" rid="CR26">26</xref>]. Community prescribing guidelines then encourage at least monthly OAT reviews with their GP [<xref ref-type="bibr" rid="CR27">27</xref>], thereby affording regular opportunities to identify and respond to other concurrent health issues.</p><p id="Par7">International studies of cohorts of people receiving OAT have found that retention in OAT is associated with increased rates of primary healthcare contact [<xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>], use of pathology services [<xref ref-type="bibr" rid="CR30">30</xref>], and receipt of prescription medication [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Further, receipt of buprenorphine-based OAT prescribed in primary healthcare settings has been found to be associated with higher rates of chronic disease screening than in people prescribed OAT by psychiatric specialists [<xref ref-type="bibr" rid="CR34">34</xref>], and a global systematic review and meta-analysis found that recent use of OAT was associated with elevated odds of recent hepatitis C testing and treatment uptake [<xref ref-type="bibr" rid="CR35">35</xref>]. However, other studies have found that compared to the general population, people receiving OAT were less likely to receive chronic disease and cancer screening and imaging, despite attending primary healthcare services at greater rates [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Few Australian studies have explored the relationship between OAT and broader primary healthcare engagement, reporting conflicting results. A study of COVID-19 vaccine uptake among people who injected drugs found increased odds of vaccine uptake among people receiving OAT [<xref ref-type="bibr" rid="CR36">36</xref>]. Another reported that people who accessed community OAT programmes used GP and pathology services at approximately three times the rate of the general population, but accessed other health services and procedures (e.g. therapeutic procedures) at reduced rates [<xref ref-type="bibr" rid="CR37">37</xref>]. In contrast, others found no association between current OAT use and past-month non-OAT GP contact [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par8">How accessing OAT after release from prison influences the use of primary healthcare by people released from prison is unknown. Previous Australian research examining use of primary healthcare after release from prison [e.g. <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. has not considered its relationship with use of OAT. Similarly, Australian studies of use of OAT after release from prison [e.g. <xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR43">43</xref>] have not examined primary healthcare use. In the United States, Howell et al. [<xref ref-type="bibr" rid="CR44">44</xref>] compared individual rates of healthcare use before a period of imprisonment during which participants enrolled in a state-wide prison-based OAT programme, with rates of healthcare use after release. They found that rates of non-acute outpatient care, hepatitis C antiviral, and OAT medication dispensations were significantly greater following imprisonment and OAT enrolment than pre-imprisonment, but no differences in rates of dispensation of psychiatric, human immunodeficiency antivirals or chemotherapy medications, and reduced dispensation of non-OAT opioid and benzodiazepine medication [<xref ref-type="bibr" rid="CR44">44</xref>]. However, this study did not explore use of OAT post-release as an exposure.</p><p id="Par9">To address these knowledge gaps, we used data from a prospective cohort study of men who injected drugs regularly prior to a period of imprisonment in Victoria, Australia, to compare rates of (1) standard community primary healthcare; (2) a broader range of community primary healthcare services; and (3) medication dispensation, between those who did and did not use OAT post-release.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Setting</title><p id="Par10">This research was conducted in Victoria, Australia. Victoria had a population of 6,649,200 people at 30 June 2021 [<xref ref-type="bibr" rid="CR45">45</xref>], making it Australia&#8217;s second most populous state. Victoria&#8217;s adult imprisonment rate rose from 110 people per 100,000 adult population in 2011 to 139 people per 100,000 adult population in 2021 [<xref ref-type="bibr" rid="CR46">46</xref>]. OAT is available in all Victorian prisons. People receiving community-based OAT when imprisoned can continue OAT during imprisonment, and others may commence OAT in prison following clinical assessment [<xref ref-type="bibr" rid="CR26">26</xref>]. Methadone and sublingual buprenorphine-naloxone were available as OAT medicines in Victorian prisons during data collection, but methadone is the Department of Justice and Community Safety (DJCS) preferred medicine for people commencing OAT in prison due a lower potential for diversion [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par11">Shortly before release from prison, people receiving OAT are referred to a private community-based pharmacist with a prescription for daily OAT dispensation for a maximum of seven days, and also to a GP based in comprehensive primary healthcare for ongoing OAT prescribing. Victoria does not operate any public OAT clinics (prescribing or dispensing) [<xref ref-type="bibr" rid="CR47">47</xref>]. GP visits are fully subsidised under the Medicare Benefits Schedule (MBS), Australia&#8217;s universal primary healthcare financing scheme, although some GPs may charge gap fees to the consumer. Consumers are required to attend a private pharmacy for supervised daily dosing. Consumers may be approved for unsupervised (i.e. take-home) doses by their prescribing GP following clinical assessment [<xref ref-type="bibr" rid="CR27">27</xref>]. Consumers are charged a daily OAT dispensing fee by pharmacies, typically AUD$5/day [<xref ref-type="bibr" rid="CR27">27</xref>]. In Victoria the DJCS subsidises the first 28&#160;days of post-release dispensing fees [<xref ref-type="bibr" rid="CR26">26</xref>]. Victorian community-based OAT treatment guidelines recommend intensive (minimum monthly) monitoring and review of OAT for people recently released from prison [<xref ref-type="bibr" rid="CR27">27</xref>]. Urine screening for detection of illicit drug use is not a routine part of Victorian OAT programmes, but is one of a number of strategies available to prescribers when assessing suitability for unsupervised dosing [<xref ref-type="bibr" rid="CR27">27</xref>].</p></sec><sec id="Sec4"><title>Participants and data sources</title><p id="Par12">Data are from the Prison and Transition Health (PATH) Cohort Study, a prospective cohort study of 400 men recruited during a prison sentence and pending release in Victoria, Australia. Participants were recruited between September 2014 and May 2016 from one minimum-, one medium- and one maximum-security prison. PATH eligibility requirements included being sentenced (not pre-trial detention), aged 18&#160;years or older, and self-reported at least monthly injecting drug use (IDU) in the 6&#160;months preceding index imprisonment. Participants completed a baseline interview a median of 39 (IQR, 15&#8211;69) days prior to release. Follow-up interviews were conducted approximately three, 12 and 24&#160;months after release from their index sentence. Detailed PATH methodology and cohort characteristics are published elsewhere [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par13">In addition to interview participation, participants were asked if they wanted to consent to linkage of survey data to a range of health and social services databases. This analysis includes linked administrative data from the Medicare Benefits Schedule (MBS; Australia&#8217;s publicly-funded universal health financing scheme), Pharmaceutical Benefits Scheme (PBS; Australia&#8217;s publicly-funded universal medication financing scheme), National Death Index (NDI), and adult reimprisonment data from DJCS. Data linkage was conducted by the Australian Department of Human Services (MBS and PBS), DJCS (reimprisonment data), and the Australian Institute of Health and Welfare (NDI). Data custodians were supplied names (including known aliases), sex, dates of birth, last known addresses, corrections reference numbers (DJCS) and Medicare numbers, and used deterministic and probabilistic methods to link participant survey data with administrative data records [<xref ref-type="bibr" rid="CR50">50</xref>]. Ethics approvals for PATH were obtained from the Alfred Hospital Ethics Committee (79/12) DJCS (CF/14/10169) and AIHW Ethics Committee (EO2014/1/77).</p></sec><sec id="Sec5"><title>Outcomes</title><p id="Par14">To understand the breadth of health services and medications used by the study population, this study had 13 outcomes: five health service utilisation outcomes, and eight prescription medication outcomes.</p><p id="Par15">MBS data compile records of a federal-government subsidised health service used by a person, with use of multiple health services per person per day possible. Each type of MBS-listed health service is assigned an item code, used by medical practitioners when making claims to the Commonwealth Government for payment for services [<xref ref-type="bibr" rid="CR51">51</xref>]. Health services outcomes were total counts of MBS-recorded health services used by participants on or between the dates of index release and three-month follow-up. Health services outcomes were grouped according to MBS item codes, and included: (1) standard GP consultations (less than 20&#160;min), (2) extended GP consultations (at least 20&#160;min), (3) mental health GP consultations, (4) after-hours GP consultations (between 6&#160;pm and 8am, on public holidays, and after 12&#160;pm on a Saturday or on a Sunday), and (5) any pathology services. Specific MBS item codes for each outcome are provided in Appendix <xref rid="Sec17" ref-type="sec">1</xref>.</p><p id="Par16">PBS data contain dispensing records of over 900 subsidised prescription medications; with data including all Section 85-listed (dispensed via community pharmacies) medications and some Section 100 (highly specialised medications dispensed via special arrangements) medications [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Each record represents one medication dispensation event, such that dispensation of seven day&#8217;s medication, one month&#8217;s medication, or two month&#8217;s medication in one event all represent one PBS record. PBS data do not include the condition for which the medication was dispensed, therefore, data were grouped into eight medications-type outcomes according to first-level headings of the Anatomical Therapeutic Chemical (ATC) classification system [<xref ref-type="bibr" rid="CR54">54</xref>], which groups medications according to pharmacological action and body system impacted. Medication outcomes, which were aggregate counts of PBS recorded medications dispensed to participants, included: (6) total dispensations, (7) nervous system, (8) anti-infective, (9) alimentary and metabolic system, and (10) other (comprising of all remaining ATC body systems) medications dispensed. Additionally, given the elevated risk of drug-related mortality among people recently released from prison [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref>], dispensation of the following specific nervous system medications were also examined: (11) opioids (non-OAT), (12) benzodiazepines, and (13) gabapentinoids.</p></sec><sec id="Sec6"><title>Primary exposure</title><p id="Par17">The primary exposure for this study was the use of OAT after release from prison. As individual-level OAT dispensing data in Victoria were not collected in any administrative dataset during PATH observation, use of OAT was ascertained by self-report at the 3-month follow-up survey. At three-month follow-up, participants were asked: &#8220;<italic toggle="yes">Were you released from prison on [OAT]?</italic>&#8221;, <italic toggle="yes">&#8220;Have you been prescribed [OAT] since we last saw you?&#8221;, &#8220;Are you currently being prescribed [OAT]?&#8221;,</italic> and if currently on OAT at three-month interview <italic toggle="yes">&#8220;How long [days/weeks/months] have you been on [OAT] for?&#8221;</italic>. These answers were used to classify participants into one of three OAT use strata (none/partial/complete) as per Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>&#160;(below). Due to an insufficient number of participants prescribed sublingual buprenorphine-naloxone, analyses did not dissaggregate by OAT medicines.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>PATH participant inclusion and OAT exposure classification</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12954_2023_773_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec7"><title>Covariates</title><p id="Par18">Model covariates were selected following a review of literature relating healthcare use among people who use drugs [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>], people recently released from prison [<xref ref-type="bibr" rid="CR25">25</xref>], and access to healthcare in rural and regional Australia [<xref ref-type="bibr" rid="CR60">60</xref>]. Covariates derived from baseline survey data included: age (years, continuous); Aboriginal and/or Torres Strait Islander (no/yes); ever diagnosed with a mental illness (no/yes); and ever diagnosed with a chronic health condition (no/yes). Covariates derived from three-month survey included: reporting fair or poor health status (poor or fair/good or excellent); reporting current accommodation as unstable (no/yes); times moved accommodation since index release (0/1&#8201;&#8722;&#8201;2/3&#8201;+); area of residence at 3-month interview (metropolitan/regional or rural/prison); main drug injected in the preceding 30&#160;days (heroin/methamphetamine/heroin and methamphetamine/neither heroin nor methamphetamine); having a current support worker (no/yes); and current psychiatric distress assessed via the 12-Item General Health Questionnaire (GHQ-12; integer), scored according to the C-GHQ-12 scoring method [<xref ref-type="bibr" rid="CR62">62</xref>]. Further covariate descriptions are available in Appendix <xref rid="Sec18" ref-type="sec">2</xref>.</p></sec><sec id="Sec8"><title>Data analysis</title><p id="Par19">Among 400 PATH participants, five died prior to three-month follow-up (see Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Among remaining participants, 277 (70%) completed a three-month follow-up interview. Of these, nine participants were excluded from analysis because DJCS linkage occurred between index release and three-month follow-up interview, resulting in incomplete reimprisonment data and preventing calculation of time in the community. Two participants who could not be linked with MBS or PBS data were also excluded. A complete case approach was used, resulting in the exclusion of a further 11 participants due to missing covariate data, resulting in a final analysis sample of 255 participants. Differences between excluded and included participants were examined for baseline sociodemographic variables using independent sample t-tests for continuous variables and chi-square tests for categorical variables.</p><p id="Par20">Baseline descriptive statistics for sociodemographics were generated. Outcome data were skewed, so median and ranges are reported for each outcome. We considered the occurrence of zero outcomes in the data; we assumed that the probability of being able to access primary healthcare and prescription medication was greater than zero for all participants, such that all observed zeros were considered to occur by chance. Given these assumptions, and the over-dispersion of all outcomes, we used generalised linear models with a negative binomial distribution to estimate associations between the mean count of each outcome (that is, 13 models were estimated) and OAT use post-release, adjusted for other covariates. For interpretability we modelled the outcomes as rates, with days at risk in the community included in modelling as an exposure term (i.e. the count of each outcome during time at risk). As people are not eligible for MBS and PBS subsidies during imprisonment [<xref ref-type="bibr" rid="CR65">65</xref>], time at risk (days) was calculated as time between release from index sentence and three-month follow-up interview, with any time spent reimprisoned deducted from this. Reimprisonment dates were determined via linkage to DJCS data; as DJCS data were unavailable beyond three-month follow-up interviews for the whole cohort to account for time in the community, all analyses examine the period between index release and three-month follow-up interview. Model estimates were reported as crude and adjusted incidence rate ratios (IRR and AIRR) with 95% confidence intervals (95%CI). Statistical significance was set at <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05. All analyses were conducted using Stata 14.1 [<xref ref-type="bibr" rid="CR66">66</xref>].</p><p id="Par21">To assess whether relationships between use of OAT and primary healthcare use were impacted by the inclusion of participants who may not have used opioids in the observation period, and were therefore not indicated for OAT, we conducted additional sensitivity analyses. Each of the 13 models described above were refit with a restricted sample including only participants who reported at the 3-month follow-up survey any use of heroin or pharmaceutical opioids (e.g. methadone, buprenorphine, oxycodone; inclusive of prescribed and illicit/diverted) since last interview.</p></sec></sec><sec id="Sec9"><title>Results</title><sec id="Sec10"><title>Participant characteristics</title><p id="Par22">The mean age of participants (<italic toggle="yes">N</italic>&#8201;=&#8201;255) was 36&#160;years (standard deviation: 8&#160;years, see Table <xref rid="Tab1" ref-type="table">1</xref>) and 15% identified as Aboriginal and/or Torres Strait Islander peoples. Most (91%) were born in Australia, 13% reported being employed prior to index imprisonment, and 20% had completed secondary school. Most (84%) reported ever having been diagnosed with a mental illness and 64% reported ever having been diagnosed with a chronic health condition. At three-month follow-up, 50% of participants were residing in a metropolitan area, and most reported their main drug injected in the past 30&#160;days as methamphetamine (28%), heroin (12%) or a combination of the two (21%). Over half (58%) of participants reported no use of OAT since index release, 13% reported partial OAT use, and 29% reported complete OAT use. No statistically significant differences in baseline characteristics were found between participants included and excluded (<italic toggle="yes">n</italic>&#8201;=&#8201;143) from analysis (see Appendix <xref rid="Sec19" ref-type="sec">3</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Participant characteristics at baseline and three-month follow-up interview (N&#8201;=&#8201;255)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">n (%<sup>a</sup>)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Baseline</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Age (mean, [SD<sup>b</sup>])</td><td char="(" align="char" colspan="1" rowspan="1">36 (8)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Aboriginal and/or Torres Strait Islander</td><td char="(" align="char" colspan="1" rowspan="1">40 (16)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Chronic health condition</td><td char="(" align="char" colspan="1" rowspan="1">170 (67)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Mental health condition</td><td char="(" align="char" colspan="1" rowspan="1">213 (84)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Area of residence</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Metropolitan</td><td char="(" align="char" colspan="1" rowspan="1">129 (51)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Regional</td><td char="(" align="char" colspan="1" rowspan="1">84 (33)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Prison</td><td char="(" align="char" colspan="1" rowspan="1">42 (16)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Times moved accommodation</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;0</td><td char="(" align="char" colspan="1" rowspan="1">110 (43)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;1&#8211;2</td><td char="(" align="char" colspan="1" rowspan="1">75 (29)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;3&#8201;+&#8201;</td><td char="(" align="char" colspan="1" rowspan="1">70 (27)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Current accommodation unstable</td><td char="(" align="char" colspan="1" rowspan="1">40 (16)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Main drug injected in past 30&#160;days</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Heroin</td><td char="(" align="char" colspan="1" rowspan="1">32 (13)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Methamphetamine</td><td char="(" align="char" colspan="1" rowspan="1">72 (28)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Methamphetamine and heroin</td><td char="(" align="char" colspan="1" rowspan="1">53 (21)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Neither methamphetamine or heroin</td><td char="(" align="char" colspan="1" rowspan="1">98 (38)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;GHQ-12 score (median, [IQR<sup>c</sup>])</td><td char="(" align="char" colspan="1" rowspan="1">3 (1&#8211;6)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Self-reported fair or poor health</td><td char="(" align="char" colspan="1" rowspan="1">75 (29)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Current support worker</td><td char="(" align="char" colspan="1" rowspan="1">72 (28)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT exposure</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;None</td><td char="(" align="char" colspan="1" rowspan="1">148 (58)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Partial</td><td char="(" align="char" colspan="1" rowspan="1">32 (13)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;&#160;&#160;Complete</td><td char="(" align="char" colspan="1" rowspan="1">75 (29)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Percentages may not add to 100% due to rounding; <sup>b</sup>Standard deviation; <sup>c</sup>Interquartile range</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Primary healthcare utilisation and OAT</title><p id="Par23">Aggregate counts, summary statistics, and crude and adjusted IRR for each health service outcome (outcomes 1&#8211;5) stratified by post-release OAT use are shown in Table <xref rid="Tab2" ref-type="table">2</xref>, with extended summary statistics available in Appendix <xref rid="Sec20" ref-type="sec">4</xref>. A total of 1113 GP consultations was observed, with 201 participants accessing at least one consultation. Standard GP consultations (<italic toggle="yes">n</italic>&#8201;=&#8201;697, 63%) were the most commonly accessed, followed by extended GP consultations (<italic toggle="yes">n</italic>&#8201;=&#8201;194, 17%).<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Item totals, median and range, for each level of opioid agonist treatment (OAT) use (None: <italic toggle="yes">n</italic>&#8201;=&#8201;148, Partial: <italic toggle="yes">n</italic>&#8201;=&#8201;32, Complete: <italic toggle="yes">n</italic>&#8201;=&#8201;75), unadjusted (IRR) and adjusted incidence rate ratios (AIRR) comparing use of primary healthcare services across different levels of post-release OAT use</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Outcome</th><th align="left" colspan="1" rowspan="1">Total count<sup>a</sup></th><th align="left" colspan="1" rowspan="1">Median (range)</th><th align="left" colspan="1" rowspan="1">IRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">AIRR<sup>b</sup> (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1. Standard consultations</td><td char="." align="char" colspan="1" rowspan="1">697</td><td char="(" align="char" colspan="1" rowspan="1">2 (0&#8211;30)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">227</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;15)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">127</td><td char="(" align="char" colspan="1" rowspan="1">3.5 (0&#8211;19)</td><td align="left" colspan="1" rowspan="1">2.71 (1.73&#8211;4.26)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">3.02 (1.88&#8211;4.86)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">343</td><td char="(" align="char" colspan="1" rowspan="1">4 (0&#8211;30)</td><td align="left" colspan="1" rowspan="1">3.33 (2.39&#8211;4.66)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">3.66 (2.57&#8211;5.23)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">2. Extended consultations</td><td char="." align="char" colspan="1" rowspan="1">194</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">82</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">33</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">2.07 (1.17&#8211;3.66)</td><td char="." align="char" colspan="1" rowspan="1">0.012</td><td align="left" colspan="1" rowspan="1">2.56 (1.41&#8211;4.67)</td><td char="." align="char" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">79</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;8)</td><td align="left" colspan="1" rowspan="1">2.19 (1.43&#8211;3.36)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.55 (1.60&#8211;4.07)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">3. Mental health consultations</td><td char="." align="char" colspan="1" rowspan="1">136</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;7)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">57</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;7)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;7)</td><td align="left" colspan="1" rowspan="1">2.20 (1.19&#8211;4.06)</td><td char="." align="char" colspan="1" rowspan="1">0.012</td><td align="left" colspan="1" rowspan="1">2.71 (1.42&#8211;5.20)</td><td char="." align="char" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">52</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;6)</td><td align="left" colspan="1" rowspan="1">2.00 (1.24&#8211;3.23)</td><td char="." align="char" colspan="1" rowspan="1">0.004</td><td align="left" colspan="1" rowspan="1">2.27 (1.33&#8211;3.87)</td><td char="." align="char" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">4. After-hours consultations</td><td char="." align="char" colspan="1" rowspan="1">86</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;9)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">29</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;6)</td><td align="left" colspan="1" rowspan="1">4.85 (2.49&#8211;9.47)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">4.61 (2.24&#8211;9.48)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">31</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;9)</td><td align="left" colspan="1" rowspan="1">2.22 (1.23&#8211;4.01)</td><td char="." align="char" colspan="1" rowspan="1">0.008</td><td align="left" colspan="1" rowspan="1">1.56 (0.78&#8211;3.10)</td><td char="." align="char" colspan="1" rowspan="1">0.207</td></tr><tr><td align="left" colspan="1" rowspan="1">5. Pathology items</td><td char="." align="char" colspan="1" rowspan="1">353</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;26)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">153</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">37</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;7)</td><td align="left" colspan="1" rowspan="1">1.24 (0.72&#8211;2.12)</td><td char="." align="char" colspan="1" rowspan="1">0.434</td><td align="left" colspan="1" rowspan="1">1.26 (0.71&#8211;2.23)</td><td char="." align="char" colspan="1" rowspan="1">0.426</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">163</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;26)</td><td align="left" colspan="1" rowspan="1">2.51 (1.74&#8211;3.62)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.30 (1.52&#8211;3.48)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Between date of index release and three-month follow-up; <sup>b</sup>Adjusted for age at baseline, Aboriginal or Torres Strait Islander, self-reported health status, main drug injected in the preceding 30&#160;days, GHQ-12 score, area of residence, ever diagnosed with a mental illness, ever diagnosed with a chronic health condition, times moved since last interview, accommodation stability and current support worker</p></table-wrap-foot></table-wrap></p><p id="Par24">In each multivariable analysis, complete retention in OAT, compared to no OAT, was associated with an increased rate of standard GP consultations (outcome 1), extended GP consultations (outcome 2), and mental health GP consultations (outcome 3) and pathology services (outcome 5). Partial OAT, compared to no OAT, was associated with an increased rate of standard GP consultations (outcome 1), extended GP consultations (outcome 2), mental health GP consultations (outcome 3) and after-hours GP consultations (see Table <xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par25">Complete adjusted models for each healthcare utilisation outcome are available as (Appendix <xref rid="Sec21" ref-type="sec">5</xref>).</p></sec><sec id="Sec12"><title>Medication dispensation and OAT</title><p id="Par26">Aggregate counts, summary statistics, and crude and adjusted IRR for each prescription medication outcome (outcomes 6&#8211;13) stratified by post-release OAT use are shown in Table <xref rid="Tab3" ref-type="table">3</xref>. A total of 1188 dispensations occurred during observation, with 159 participants being dispensed at least one medication. Nervous system medications accounted for 75% (<italic toggle="yes">n</italic>&#8201;=&#8201;894) of dispensations. Benzodiazepines accounted for 39% (<italic toggle="yes">n</italic>&#8201;=&#8201;353) of nervous system medication dispensations; of these, diazepam (<italic toggle="yes">n</italic>&#8201;=&#8201;224, 63%) and oxazepam (<italic toggle="yes">n</italic>&#8201;=&#8201;78, 22%) were the most common benzodiazepines dispensed.
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Item totals, median and range, median and range for each level of opioid agonist treatment (OAT) use (None: <italic toggle="yes">n</italic>&#8201;=&#8201;148, Partial: <italic toggle="yes">n</italic>&#8201;=&#8201;32, Complete: <italic toggle="yes">n</italic>&#8201;=&#8201;75), unadjusted (IRR) and adjusted incidence rate ratios (AIRR) comparing primary healthcare-based medication dispensation across different levels of post-release OAT use</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Outcome</th><th align="left" colspan="1" rowspan="1">Total count<sup>a</sup></th><th align="left" colspan="1" rowspan="1">Median (range)</th><th align="left" colspan="1" rowspan="1">IRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">AIRR<sup>b</sup> (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">6. Total dispensations</td><td char="." align="char" colspan="1" rowspan="1">1188</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">548</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;36)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">155</td><td char="(" align="char" colspan="1" rowspan="1">2 (0&#8211;28)</td><td align="left" colspan="1" rowspan="1">1.35 (0.88&#8211;2.07)</td><td char="." align="char" colspan="1" rowspan="1">0.176</td><td align="left" colspan="1" rowspan="1">1.88 (1.19&#8211;2.98)</td><td align="left" colspan="1" rowspan="1">0.007</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">485</td><td char="(" align="char" colspan="1" rowspan="1">3 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1">1.83 (1.34&#8211;2.50)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.40 (1.71&#8211;3.37)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">7. ATC: Nervous system</td><td char="." align="char" colspan="1" rowspan="1">894</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">338</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;29)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">135</td><td char="(" align="char" colspan="1" rowspan="1">1.5 (0&#8211;27)</td><td align="left" colspan="1" rowspan="1">1.90 (1.22&#8211;2.95)</td><td char="." align="char" colspan="1" rowspan="1">0.004</td><td align="left" colspan="1" rowspan="1">2.59 (1.61&#8211;4.16)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">421</td><td char="(" align="char" colspan="1" rowspan="1">3 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1">2.61 (1.89&#8211;3.60)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">3.54 (2.48&#8211;5.03)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">8. ATC: Anti-infectives</td><td char="." align="char" colspan="1" rowspan="1">103</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;15)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">79</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;15)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;3)</td><td align="left" colspan="1" rowspan="1">0.57 (0.25&#8211;1.27)</td><td char="." align="char" colspan="1" rowspan="1">0.168</td><td align="left" colspan="1" rowspan="1">0.78 (0.33&#8211;1.83)</td><td align="left" colspan="1" rowspan="1">0.568</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;2)</td><td align="left" colspan="1" rowspan="1">0.41 (0.22&#8211;0.76)</td><td char="." align="char" colspan="1" rowspan="1">0.005</td><td align="left" colspan="1" rowspan="1">0.51 (0.26&#8211;1.00)</td><td align="left" colspan="1" rowspan="1">0.05</td></tr><tr><td align="left" colspan="1" rowspan="1">9. ATC: Alimentary &amp; metabolic<sup>c</sup></td><td char="." align="char" colspan="1" rowspan="1">64</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;11)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">41</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;11)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.22 (0.05&#8211;0.99)</td><td char="." align="char" colspan="1" rowspan="1">0.048</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">1.10 (0.60&#8211;2.01)</td><td char="." align="char" colspan="1" rowspan="1">0.755</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">10. ATC: Other</td><td char="." align="char" colspan="1" rowspan="1">127</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">90</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">0.45 (0.20&#8211;1.01)</td><td char="." align="char" colspan="1" rowspan="1">0.052</td><td align="left" colspan="1" rowspan="1">0.70 (0.29&#8211;1.70)</td><td align="left" colspan="1" rowspan="1">0.431</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;8)</td><td align="left" colspan="1" rowspan="1">0.61 (0.36&#8211;1.03)</td><td char="." align="char" colspan="1" rowspan="1">0.062</td><td align="left" colspan="1" rowspan="1">0.72 (0.39&#8211;1.33)</td><td align="left" colspan="1" rowspan="1">0.289</td></tr><tr><td align="left" colspan="1" rowspan="1">11. Opioids</td><td char="." align="char" colspan="1" rowspan="1">125</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;17)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">80</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;17)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">0.58 (0.27&#8211;1.26)</td><td char="." align="char" colspan="1" rowspan="1">0.167</td><td align="left" colspan="1" rowspan="1">0.89 (0.36&#8211;2.21)</td><td align="left" colspan="1" rowspan="1">0.797</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">35</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1">0.94 (0.57&#8211;1.54)</td><td char="." align="char" colspan="1" rowspan="1">0.801</td><td align="left" colspan="1" rowspan="1">1.08 (0.57&#8211;2.06)</td><td align="left" colspan="1" rowspan="1">0.808</td></tr><tr><td align="left" colspan="1" rowspan="1">12. Benzodiazepines</td><td char="." align="char" colspan="1" rowspan="1">353</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;45)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">74</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;25)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">68</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;27)</td><td align="left" colspan="1" rowspan="1">4.29 (2.55&#8211;7.22)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">4.99 (2.81&#8211;8.85)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">211</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;45)</td><td align="left" colspan="1" rowspan="1">6.39 (4.30&#8211;9.50)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">8.30 (5.28&#8211;13.04)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">13. Gabapentinoids<sup>d</sup></td><td char="." align="char" colspan="1" rowspan="1">114</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;14)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;9)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">33</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;14)</td><td align="left" colspan="1" rowspan="1">6.76 (3.55&#8211;12.87)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">6.78 (3.34&#8211;13.77)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">53</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;11)</td><td align="left" colspan="1" rowspan="1">3.87 (2.24&#8211;6.70)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">4.34 (2.37&#8211;7.94)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Between date of index release and three-month follow-up; <sup>b</sup>Adjusted for age at baseline, Aboriginal or Torres Strait Islander, self-reported health status, main drug injected in the preceding 30&#160;days, GHQ-12 score, area of residence, ever diagnosed with a mental illness, ever diagnosed with a chronic health condition, times moved since last interview, accommodation stability and current support worker; <sup>c</sup>An adjusted model was not estimated for associations between OAT and Alimentary &amp; Metabolic dispensations due to an insufficient count among people reporting partial OAT; <sup>d</sup>Adjusted model does not include covariate of main drug injected in the preceding 30&#160;days due to an insufficient cell count in one level of this covariate</p></table-wrap-foot></table-wrap></p><p id="Par27">In each multivariable analysis, complete retention in OAT was associated with increased rates of total medication, nervous system, benzodiazepine, and gabapentinoid dispensations (see Table <xref rid="Tab3" ref-type="table">3</xref>). Partial OAT was also associated with an increased rate of total medication, nervous system, benzodiazepine, and gabapentinoid dispensations.</p><p id="Par28">Complete adjusted models for each prescription medication outcome are available as (Appendix <xref rid="Sec22" ref-type="sec">6</xref>).</p><p id="Par29">A total of 195 (76% of 255) participants reported at least one episode of opioid use between baseline and three-month follow-up interviews, and were included in sensitivity analyses. Associations between use of OAT and primary healthcare among participants reporting opioid use were consistent with those observed in the primary analysis (see Table <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Sensitivity analysis of item totals, median and range, median and range for each level of OAT use (None: <italic toggle="yes">n</italic>&#8201;=&#8201;88, Partial: <italic toggle="yes">n</italic>&#8201;=&#8201;32, Complete: <italic toggle="yes">n</italic>&#8201;=&#8201;75), unadjusted (IRR) and adjusted incidence rate ratios (AIRR) comparing primary healthcare-based medication dispensation across different levels of post-release OAT use among participants who reported any opioid use since baseline interview (<italic toggle="yes">N</italic>&#8201;=&#8201;195)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Outcome</th><th align="left" colspan="1" rowspan="1">Aggregate count<sup>a</sup></th><th align="left" colspan="1" rowspan="1">Median (range)</th><th align="left" colspan="1" rowspan="1">IRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">AIRR<sup>b</sup> (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1. Standard consultations</td><td char="." align="char" colspan="1" rowspan="1">608</td><td char="(" align="char" colspan="1" rowspan="1">2 (0&#8211;30)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">138</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;15)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">127</td><td char="(" align="char" colspan="1" rowspan="1">3.5 (0&#8211;19)</td><td align="left" colspan="1" rowspan="1">2.76 (1.70&#8211;4.47)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.85 (1.70&#8211;4.77)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">343</td><td char="(" align="char" colspan="1" rowspan="1">4 (0&#8211;30)</td><td align="left" colspan="1" rowspan="1">3.39 (2.33&#8211;4.94)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">3.52 (2.35&#8211;5.27)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">2. Extended consultations</td><td char="." align="char" colspan="1" rowspan="1">152</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">40</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">33</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">2.59 (1.38&#8211;4.85)</td><td char="." align="char" colspan="1" rowspan="1">0.003</td><td align="left" colspan="1" rowspan="1">2.96 (1.51&#8211;5.79)</td><td align="left" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">79</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;8)</td><td align="left" colspan="1" rowspan="1">2.75 (1.66&#8211;4.54)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.85 (1.66&#8211;4.89)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">3. Mental health consultations</td><td char="." align="char" colspan="1" rowspan="1">103</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;7)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">24</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;5)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;7)</td><td align="left" colspan="1" rowspan="1">3.26 (1.62&#8211;6.58)</td><td char="." align="char" colspan="1" rowspan="1">0.001</td><td align="left" colspan="1" rowspan="1">3.13 (1.51&#8211;6.49)</td><td align="left" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">52</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;6)</td><td align="left" colspan="1" rowspan="1">2.97 (1.66&#8211;5.34)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.71 (1.45&#8211;5.08)</td><td align="left" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">4. After-hours consultations</td><td char="." align="char" colspan="1" rowspan="1">73</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;9)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;2)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;6)</td><td align="left" colspan="1" rowspan="1">5.26 (2.46&#8211;11.22)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">4.88 (2.12&#8211;11.25)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">31</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;9)</td><td align="left" colspan="1" rowspan="1">2.41 (1.21&#8211;4.79)</td><td char="." align="char" colspan="1" rowspan="1">0.012</td><td align="left" colspan="1" rowspan="1">1.76 (0.79&#8211;3.92)</td><td align="left" colspan="1" rowspan="1">0.168</td></tr><tr><td align="left" colspan="1" rowspan="1">5. Pathology items</td><td char="." align="char" colspan="1" rowspan="1">275</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;26)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">75</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">37</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;7)</td><td align="left" colspan="1" rowspan="1">1.52 (0.85&#8211;2.72)</td><td char="." align="char" colspan="1" rowspan="1">0.154</td><td align="left" colspan="1" rowspan="1">1.49 (0.79&#8211;2.82)</td><td align="left" colspan="1" rowspan="1">0.216</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">163</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;26)</td><td align="left" colspan="1" rowspan="1">3.09 (2.02&#8211;4.71)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.76 (1.67&#8211;4.58)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">6. Total prescriptions</td><td char="." align="char" colspan="1" rowspan="1">925</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">285</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;36)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">155</td><td char="(" align="char" colspan="1" rowspan="1">2 (0&#8211;28)</td><td align="left" colspan="1" rowspan="1">1.58 (1.00&#8211;2.50)</td><td char="." align="char" colspan="1" rowspan="1">0.050</td><td align="left" colspan="1" rowspan="1">2.00 (1.21&#8211;3.29)</td><td align="left" colspan="1" rowspan="1">0.007</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">485</td><td char="(" align="char" colspan="1" rowspan="1">3 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1">2.15 (1.51&#8211;3.05)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.65 (1.79&#8211;3.93)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">7. ATC: nervous system</td><td char="." align="char" colspan="1" rowspan="1">762</td><td char="(" align="char" colspan="1" rowspan="1">1 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">206</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;29)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">135</td><td char="(" align="char" colspan="1" rowspan="1">1.5 (0&#8211;27)</td><td align="left" colspan="1" rowspan="1">1.89 (1.19&#8211;3.03)</td><td char="." align="char" colspan="1" rowspan="1">0.007</td><td align="left" colspan="1" rowspan="1">2.60 (1.55&#8211;4.37)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">421</td><td char="(" align="char" colspan="1" rowspan="1">3 (0&#8211;49)</td><td align="left" colspan="1" rowspan="1">2.60 (1.82&#8211;3.73)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">3.61 (2.38&#8211;5.47)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">8. ATC: anti-infectives</td><td char="." align="char" colspan="1" rowspan="1">53</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">29</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;3)</td><td align="left" colspan="1" rowspan="1">0.93 (0.39&#8211;2.21)</td><td char="." align="char" colspan="1" rowspan="1">0.864</td><td align="left" colspan="1" rowspan="1">0.92 (0.37&#8211;2.32)</td><td align="left" colspan="1" rowspan="1">0.866</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;2)</td><td align="left" colspan="1" rowspan="1">0.66 (0.33&#8211;1.34)</td><td char="." align="char" colspan="1" rowspan="1">0.252</td><td align="left" colspan="1" rowspan="1">0.75 (0.34&#8211;1.65)</td><td align="left" colspan="1" rowspan="1">0.474</td></tr><tr><td align="left" colspan="1" rowspan="1">9. ATC: Alimentary &amp; metabolic<sup>c</sup></td><td char="." align="char" colspan="1" rowspan="1">41</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;6)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;6)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.31 (0.07&#8211;1.43)</td><td char="." align="char" colspan="1" rowspan="1">0.134</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">1.53 (0.75&#8211;3.11)</td><td char="." align="char" colspan="1" rowspan="1">0.241</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">10. ATC: Other</td><td char="." align="char" colspan="1" rowspan="1">69</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;9)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">32</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;9)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">0.79 (0.33&#8211;1.86)</td><td char="." align="char" colspan="1" rowspan="1">0.589</td><td align="left" colspan="1" rowspan="1">0.75 (0.27&#8211;2.03)</td><td align="left" colspan="1" rowspan="1">0.568</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;8)</td><td align="left" colspan="1" rowspan="1">1.07 (0.58&#8211;1.95)</td><td char="." align="char" colspan="1" rowspan="1">0.836</td><td align="left" colspan="1" rowspan="1">0.87 (0.43&#8211;1.78)</td><td align="left" colspan="1" rowspan="1">0.708</td></tr><tr><td align="left" colspan="1" rowspan="1">11. Opioids</td><td char="." align="char" colspan="1" rowspan="1">118</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;17)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">73</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;17)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td align="left" colspan="1" rowspan="1">0.37 (0.17&#8211;0.83)</td><td char="." align="char" colspan="1" rowspan="1">0.015</td><td align="left" colspan="1" rowspan="1">0.60 (0.23&#8211;1.55)</td><td align="left" colspan="1" rowspan="1">0.289</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">35</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;10)</td><td align="left" colspan="1" rowspan="1">0.61 (0.36&#8211;1.02)</td><td char="." align="char" colspan="1" rowspan="1">0.059</td><td align="left" colspan="1" rowspan="1">0.62 (0.31&#8211;1.28)</td><td align="left" colspan="1" rowspan="1">0.197</td></tr><tr><td align="left" colspan="1" rowspan="1">12. Benzodiazepines</td><td char="." align="char" colspan="1" rowspan="1">334</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;45)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">55</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;25)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">68</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;27)</td><td align="left" colspan="1" rowspan="1">3.60 (2.06&#8211;6.26)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">4.59 (2.42&#8211;8.70)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">211</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;45)</td><td align="left" colspan="1" rowspan="1">5.35 (3.44&#8211;8.32)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">7.19 (4.23&#8211;12.20)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">13. Gabapentinoids<sup>d</sup></td><td char="." align="char" colspan="1" rowspan="1">102</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;14)</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: None</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;8)</td><td align="left" colspan="1" rowspan="1">REF</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Partial</td><td char="." align="char" colspan="1" rowspan="1">33</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;14)</td><td align="left" colspan="1" rowspan="1">7.05 (3.39&#8211;14.69)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">7.13 (3.21&#8211;15.86)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;OAT: Complete</td><td char="." align="char" colspan="1" rowspan="1">53</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;11)</td><td align="left" colspan="1" rowspan="1">4.04 (2.11&#8211;7.75)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">4.67 (2.32&#8211;9.38)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Between date of index release and three-month follow-up; <sup>b</sup>Adjusted for age at baseline, Aboriginal or Torres Strait Islander, self-reported health status, main drug injected in the preceding 30&#160;days, GHQ-12 score, area of residence, ever diagnosed with a mental illness, ever diagnosed with a chronic health condition, times moved since last interview, accommodation stability and current support worker; <sup>c</sup>An adjusted model was not estimated for associations between OAT and Alimentary &amp; Metabolic dispensations due to an insufficient count among people reporting partial OAT; <sup>d</sup>Adjusted model does not include covariate of main drug injected in the preceding 30&#160;days due to an insufficient cell count in one level of this covariate</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par30">Among a cohort of men recently released from prison who reported regular IDU prior to imprisonment, we found that use of OAT in the post-release observation period was associated with increased use of standard and extended GP consultations in primary healthcare settings compared to those reporting no OAT use, consistent with existing literature [<xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. These elevated rates of primary healthcare attendance among people using OAT provide opportunities to address concurrent health priorities and support improved health outcomes among people recently released from prison. We also observed increased use of mental health GP consultations among people reporting partial or complete post-release OAT use, although the proportion of participants accessing these services during follow-up (32%) was low given the very high prevalence of mental health problems in the cohort. While previous studies have found elevated use of pathology services among people using OAT [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], this was only observed among people reporting complete OAT use in this study. We also found increased use of after-hours GP services among people reporting partial OAT use, but not complete OAT.
</p><p id="Par31">While overall rates of total medication dispensation were higher among both partial and complete OAT groups than in the no OAT group, only medication dispensations for the nervous system were elevated when dispensations were analysed according to ATC group. We also observed increased rates of benzodiazepine and gabapentinoid prescription among people who accessed OAT, compared to people who did not. These findings were unexpected, given prior evidence of reduced benzodiazepine prescription among people using OAT [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR67">67</xref>] and Victorian community-based OAT prescribing guidelines repeatedly cautioning against concurrent prescription of central nervous system depressants due to the risk of multiple drug toxicity and drug-related mortality [<xref ref-type="bibr" rid="CR27">27</xref>].</p><sec id="Sec14"><title>Implications</title><p id="Par32">Studies have demonstrated the importance of integrated health and substance use treatment services in meeting the health needs of people who inject drugs [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. In our study, most GP consultations in the first three months after release from prison were standard consultations of less than 20&#160;min duration. While MBS data do not include details of healthcare provided during GP consultations, short consultation durations may result in GPs prioritising initiation of OAT and/or stabilisation of OAT dose, potentiating other health issues being un- or under-treated. Diagnostic overshadowing is a well-recognised concern for people with complex health needs, after release from prison [<xref ref-type="bibr" rid="CR70">70</xref>]. Routine use of extended consultations for people recently released from prison using OAT could support holistic individual health plans which concurrently address other health issues, including mental health, blood borne virus and chronic disease screening and treatment. However, the use of extended consultations may require increased OAT prescribing capacity. At June 2020, approximately eleven per cent of Victoria&#8217;s GPs were accredited to prescribe OAT [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Currently in Victoria, GPs are required to undertake specialist training to prescribe methadone-OAT or buprenorphine-OAT to six or more patients, consisting of a short online module and a day-long module [<xref ref-type="bibr" rid="CR72">72</xref>]. OAT accreditation requirements pose a barrier to recruiting new OAT prescribers and may cultivate a perception that OAT prescription is difficult [<xref ref-type="bibr" rid="CR73">73</xref>]. The abolition of training requirements for buprenorphine-OAT, which carries a reduced risk of overdose [<xref ref-type="bibr" rid="CR74">74</xref>], and the integration of methadone-OAT training into standard GP training and ongoing professional development, may increase the number of GPs prescribing OAT [<xref ref-type="bibr" rid="CR73">73</xref>].</p><p id="Par33">Our results add to the evidence supporting the health benefits of retention in OAT after release from prison. However, long-term retention in OAT after release from prison is rare [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR75">75</xref>&#8211;<xref ref-type="bibr" rid="CR78">78</xref>]; indicating the need for reforms to OAT provision. Financial barriers such as dispensing fees [<xref ref-type="bibr" rid="CR79">79</xref>&#8211;<xref ref-type="bibr" rid="CR81">81</xref>] and indirect costs including transport [<xref ref-type="bibr" rid="CR80">80</xref>] reduce OAT retention. Subsidising OAT in line with other PBS-listed prescription medications in Australia would improve health equity and affordability [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR82">82</xref>], while increased access to unsupervised doses [<xref ref-type="bibr" rid="CR80">80</xref>] may reduce indirect costs. Alternative OAT medications such as injectable diamorphine [<xref ref-type="bibr" rid="CR83">83</xref>&#8211;<xref ref-type="bibr" rid="CR85">85</xref>] are safe, effective and may support retention among people not retained in methadone- or buprenorphine-OAT. Routine clinical assessment supported by machine learning tools may support early identification of people at risk of premature OAT discontinuation, enabling early intervention [<xref ref-type="bibr" rid="CR86">86</xref>], and online tools may also support retention [<xref ref-type="bibr" rid="CR87">87</xref>&#8211;<xref ref-type="bibr" rid="CR89">89</xref>]. Use of such programmes to support improved retention should be explored.</p><p id="Par34">Improvements to the prison-to-community OAT referral process may provide additional opportunities to improve health among people receiving OAT after release from prison. In Victoria, prison discharge summaries, which are also used to support prison-to-community OAT referrals, contain fields for listing other concurrent physical and mental health issues which could be used to help GPs target care and assist in informing additional health screens. A randomised trial in Queensland, Australia, showed that active referral and provision of health summaries during the transition from prison to community increased primary care and mental healthcare contacts for at least 6&#160;months post-release [<xref ref-type="bibr" rid="CR39">39</xref>]. Currently, completion rates of non-OAT health information in OAT referrals in Victoria are unknown. However, research from New South Wales, Australia, found that women on OAT were no more likely to have prison health information transferred to community-based healthcare than women who were not using OAT [<xref ref-type="bibr" rid="CR90">90</xref>].
</p><p id="Par35">Australian [e.g. <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR91">91</xref>] and international research [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>] has consistently shown an elevated risk of drug overdose among people recently released from prison. Both benzodiazepines [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>] and gabapentinoids [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref>] are associated with an increased risk of drug-related morbidity and mortality. Although the majority of benzodiazepines dispensed to our cohort were lower potency medications, concurrent prescription of central nervous system depressants such as these may increase the risk of overdose among people using OAT post-release. This risk may be most pronounced among people who initiate or discontinue OAT in the immediate post-release period, as the weeks pre- and post-OAT are also associated with an elevated risk of opioid-related mortality [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. While previous research has found that retention in OAT after release from prison reduces the risk of opioid-related mortality [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR97">97</xref>], it is unclear whether the high rates of benzodiazepine and gabapentinoid use may erode this protective effect. Future research should examine the reasons for benzodiazepine and gabapentinoid prescription during community re-entry, including whether they are prescribed and dispensed by the same healthcare providers, and any subsequent impact on the risk of drug overdose.</p></sec><sec id="Sec15"><title>Limitations and strengths</title><p id="Par36">Several limitations should be considered when interpreting these findings. First, as the sample included only men who were regularly injecting drugs prior to imprisonment, these results cannot be generalised to other groups such as women, young people, people released from pre-trial detention, or people who do not inject drugs. In particular, for women in prison, the increased burden of many physical health, mental health and substance-related conditions [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], reproductive health needs [<xref ref-type="bibr" rid="CR1">1</xref>] and differing patterns of healthcare access compared to men [<xref ref-type="bibr" rid="CR5">5</xref>] may impact associations between OAT use post-release and primary healthcare utilisation. Replication of our findings in other settings will be required. Second, the sample size limited the precision of model estimates, especially for less frequent outcomes. Third, 123 participants who did not complete a 3-month follow-up interview were excluded from analysis. No differences were observed between participants included and excluded; however we cannot exclude the potential of attrition bias influencing our findings. Fourth, the absence of administrative OAT data may have introduced measurement and recall bias. Fifth, the PATH study design prevented determination of opioid dependence. As such, the &#8216;none&#8217; OAT exposure group likely includes people who were not experiencing opioid dependence, either because they had ceased or reduced use, or were primarily using drugs other than opioids, and therefore unsuitable for OAT. However, the results of sensitivity analyses which excluded people who did not report any opioid use since baseline interview were consistent with primary results. Additionally, the absence of administrative OAT data also prevented temporal analysis of OAT exposure relative to health services use for participants reporting partial OAT use, which may have offered additional insight into patterns of health service use. Sixth, these findings represent associations between use of OAT and primary healthcare in the immediate post-release period. Future research should examine whether and how these associations change over time. Seventh, MBS data do not contain details of health matters discussed or treatments provided within consultations, preventing more detailed analysis. Eighth, given the absence of daily prescribed dose and medication indication from PBS data, estimation of mean medication dispensation rates are a proxy for healthcare use and not medication consumption per se. We note that the mean number of total medication dispensations was 4.6 (standard deviation: 7.8; see Appendix <xref rid="Sec19" ref-type="sec">3</xref>) over an average of 3.7&#160;months of observation per person. Therefore, it is reasonable to use these data as a proxy for healthcare use. Finally, this analysis focused primarily on personal factors associated with health service utilisation. Despite these limitations, a key strength of this analysis was the linkage of self-report and administrative data. Administrative data provided unbiased data on frequency of primary healthcare use and medication dispensation, while self-report data allowed inclusion of covariates relating to housing stability and injecting drug use which are typically unavailable to analyses using only administrative data.</p></sec></sec><sec id="Sec16"><title>Conclusion</title><p id="Par37">People recently released from prison commonly experience significant declines in their physical and mental health. We observed higher rates of standard GP consultation in primary healthcare, and some evidence of broader primary healthcare use, including mental health consultations, among men with histories of IDU using OAT after release from prison. Retention in post-release OAT provides clear opportunities to address the concurrent health needs of people recently released from prison. Increased use of extended GP consultations among people recently released from prison who use OAT, and initiatives which support retention in OAT post-release, has the potential to support improved physical and mental health outcomes.</p></sec></body><back><app-group><app id="App1"><sec id="Sec17"><title>Appendix 1</title><p id="Par41">(See Table <table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Primary healthcare service outcomes and corresponding MBS item codes [<xref ref-type="bibr" rid="CR51">51</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Outcome</th><th align="left" colspan="1" rowspan="1">Item codes</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Standard consultations</td><td align="left" colspan="1" rowspan="1">3, 4, 23, 24</td></tr><tr><td align="left" colspan="1" rowspan="1">Extended consultations</td><td align="left" colspan="1" rowspan="1">36, 37, 44, 47</td></tr><tr><td align="left" colspan="1" rowspan="1">Mental health consultations</td><td align="left" colspan="1" rowspan="1">2700, 2701, 2712, 2713, 2715, 2717, 2721, 2725</td></tr><tr><td align="left" colspan="1" rowspan="1">After-hours consultations</td><td align="left" colspan="1" rowspan="1">5000, 5020, 5023, 5028, 5040, 5043, 5060</td></tr><tr><td align="left" colspan="1" rowspan="1">Pathology services</td><td align="left" colspan="1" rowspan="1">All category 6 item codes</td></tr></tbody></table></table-wrap><xref rid="Tab5" ref-type="table">5</xref>).</p></sec><sec id="Sec18"><title>Appendix 2</title><p id="Par42">(See Table <table-wrap id="Tab6" position="float" orientation="portrait"><label>Table 6</label><caption><p>Covariate names, type, unit of measurement and additional description notes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Covariate</th><th align="left" colspan="1" rowspan="1">Type</th><th align="left" colspan="1" rowspan="1">Unit of measurement</th><th align="left" colspan="1" rowspan="1">Notes</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1">Continuous</td><td align="left" colspan="1" rowspan="1">Years</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Aboriginal and/or Torres Strait Islander</td><td align="left" colspan="1" rowspan="1">Binary</td><td align="left" colspan="1" rowspan="1">Yes/no</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Ever diagnosed with a mental illness</td><td align="left" colspan="1" rowspan="1">Binary</td><td align="left" colspan="1" rowspan="1">Yes/no</td><td align="left" colspan="1" rowspan="1">Includes depressive, anxiety, personality, and psychotic disorders</td></tr><tr><td align="left" colspan="1" rowspan="1">Ever diagnosed with a chronic health condition</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><p>Participants were classified as having a chronic health condition if they answered &#8216;yes&#8217; at baseline interviews to ever having been diagnosed with a metabolic (e.g. diabetes), neurological (e.g. acquired brain injury, epilepsy), musculoskeletal (e.g. back injury, osteoarthritis), circulatory (e.g. hypertension, heart disease), respiratory condition (e.g. asthma, emphysema). Further, participants were also asked about &#8216;other health conditions&#8217; at baseline; these were manually reviewed, and chronic conditions (e.g. psoriasis, gastrointestinal, cancer) reported here were also classified as chronic health conditions</p><p>Infectious diseases, dental and hearing or vision conditions were not classified as, at the time of analysis, these conditions were unlikely to include routine treatment or care from general practitioners working in primary healthcare services</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Fair or poor health status</td><td align="left" colspan="1" rowspan="1">Binary</td><td align="left" colspan="1" rowspan="1">Poor or fair/good or excellent</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Current accommodation unstable</td><td align="left" colspan="1" rowspan="1">Binary</td><td align="left" colspan="1" rowspan="1">Yes/no</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Times moved accommodation since index release</td><td align="left" colspan="1" rowspan="1">Ordinal</td><td align="left" colspan="1" rowspan="1">0/1&#8201;&#8722;&#8201;2/3&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Area of residence at three-month interview</td><td align="left" colspan="1" rowspan="1">Categorical</td><td align="left" colspan="1" rowspan="1">Metropolitan/regional or rural/prison</td><td align="left" colspan="1" rowspan="1">Determined by matching self-reported residential postcode to the Australian Bureau of Statistics&#8217; Statistical Area Codes [<xref ref-type="bibr" rid="CR61">61</xref>]. Participants who were reimprisoned at three-month interview were classified as &#8216;prison&#8217;</td></tr><tr><td align="left" colspan="1" rowspan="1">Main drug injected in the preceding 30&#160;days</td><td align="left" colspan="1" rowspan="1">Categorical</td><td align="left" colspan="1" rowspan="1">Heroin/methamphetamine/heroin and methamphetamine/neither heroin nor methamphetamine</td><td align="left" colspan="1" rowspan="1">Neither heroin nor methamphetamine is comprised of people who did not report any injecting drug use (n&#8201;=&#8201;90) and people who reported injecting drugs other than heroin or methamphetamine (n&#8201;=&#8201;6) in the 30&#160;days preceding three-month follow-up interview</td></tr><tr><td align="left" colspan="1" rowspan="1">Current support worker</td><td align="left" colspan="1" rowspan="1">Binary</td><td align="left" colspan="1" rowspan="1">Yes/no</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">12-Item General Health Questionnaire (GHQ-12)</td><td align="left" colspan="1" rowspan="1">Integer</td><td align="left" colspan="1" rowspan="1">C-GHQ-12 scoring method; range: 0&#8211;12</td><td align="left" colspan="1" rowspan="1">The GHQ-12 is a standardised 12-item questionnaire which screens for poor psychiatric well-being over the preceding four weeks; higher scores indicate poorer psychiatric well-being condition [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]</td></tr></tbody></table></table-wrap><xref rid="Tab6" ref-type="table">6</xref>).</p></sec><sec id="Sec19"><title>Appendix 3</title><p id="Par43">(See Table <table-wrap id="Tab7" position="float" orientation="portrait"><label>Table 7</label><caption><p>Summary statistics of participant sociodemographic characteristics, stratified by analysis inclusion</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Excluded <italic toggle="yes">N</italic>&#8201;=&#8201;145 (%)</th><th align="left" colspan="1" rowspan="1">Included <italic toggle="yes">N</italic>&#8201;=&#8201;255 <italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (mean, SD<sup>a</sup>)</td><td char="(" align="char" colspan="1" rowspan="1">36 (9)</td><td char="(" align="char" colspan="1" rowspan="1">36 (8)</td><td char="." align="char" colspan="1" rowspan="1">0.496<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Aboriginal and/or Torres Strait Islander</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No</td><td char="(" align="char" colspan="1" rowspan="1">119 (82)</td><td char="(" align="char" colspan="1" rowspan="1">215 (84)</td><td char="." align="char" colspan="1" rowspan="1">0.561<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Yes</td><td char="(" align="char" colspan="1" rowspan="1">26 (18)</td><td char="(" align="char" colspan="1" rowspan="1">40 (16)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Born outside of Australia</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No</td><td char="(" align="char" colspan="1" rowspan="1">125 (86)</td><td char="(" align="char" colspan="1" rowspan="1">233 (91)</td><td char="." align="char" colspan="1" rowspan="1">0.105<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Yes</td><td char="(" align="char" colspan="1" rowspan="1">20 (14)</td><td char="(" align="char" colspan="1" rowspan="1">22 (9)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Unemployed before index sentence</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No</td><td char="(" align="char" colspan="1" rowspan="1">14 (10)</td><td char="(" align="char" colspan="1" rowspan="1">33 (13)</td><td char="." align="char" colspan="1" rowspan="1">0.338<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Yes</td><td char="(" align="char" colspan="1" rowspan="1">130 (90)</td><td char="(" align="char" colspan="1" rowspan="1">222 (87)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Completed secondary school</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No</td><td char="(" align="char" colspan="1" rowspan="1">126 (87)</td><td char="(" align="char" colspan="1" rowspan="1">204 (80)</td><td char="." align="char" colspan="1" rowspan="1">0.081<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Yes</td><td char="(" align="char" colspan="1" rowspan="1">19 (13)</td><td char="(" align="char" colspan="1" rowspan="1">51 (20)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">OAT<sup>d</sup> at baseline interview</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No</td><td char="(" align="char" colspan="1" rowspan="1">81 (56)</td><td char="(" align="char" colspan="1" rowspan="1">154 (60)</td><td char="." align="char" colspan="1" rowspan="1">0.376<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Yes</td><td char="(" align="char" colspan="1" rowspan="1">64 (44)</td><td char="(" align="char" colspan="1" rowspan="1">101 (40)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Lifetime health condition</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No</td><td char="(" align="char" colspan="1" rowspan="1">49 (34)</td><td char="(" align="char" colspan="1" rowspan="1">85 (33)</td><td char="." align="char" colspan="1" rowspan="1">0.925<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Yes</td><td char="(" align="char" colspan="1" rowspan="1">96 (66)</td><td char="(" align="char" colspan="1" rowspan="1">170 (67)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Lifetime mental illness (N&#8201;=&#8201;397)</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No</td><td char="(" align="char" colspan="1" rowspan="1">31 (22)</td><td char="(" align="char" colspan="1" rowspan="1">42 (16)</td><td char="." align="char" colspan="1" rowspan="1">0.186<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Yes</td><td char="(" align="char" colspan="1" rowspan="1">111 (78)</td><td char="(" align="char" colspan="1" rowspan="1">213 (84)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Main drug injected in the month prior to index imprisonment</td><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Heroin only</td><td char="(" align="char" colspan="1" rowspan="1">21 (14)</td><td char="(" align="char" colspan="1" rowspan="1">37 (15)</td><td char="." align="char" colspan="1" rowspan="1">0.188<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Methamphetamine only</td><td char="(" align="char" colspan="1" rowspan="1">48 (33)</td><td char="(" align="char" colspan="1" rowspan="1">94 (37)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;Heroin and methamphetamine</td><td char="(" align="char" colspan="1" rowspan="1">63 (43)</td><td char="(" align="char" colspan="1" rowspan="1">87 (34)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#160;No heroin or methamphetamine</td><td char="(" align="char" colspan="1" rowspan="1">13 (9)</td><td char="(" align="char" colspan="1" rowspan="1">37 (15)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">GHQ-12<sup>e</sup> score (mean, SD<sup>a</sup>)</td><td char="(" align="char" colspan="1" rowspan="1">5 (3)</td><td char="(" align="char" colspan="1" rowspan="1">5 (3)</td><td char="." align="char" colspan="1" rowspan="1">0.435<sup>b</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Standard deviation, <sup>b</sup>independent samples two-tailed t-test, <sup>c</sup>chi-square test, <sup>d</sup>opioid agonist treatment, <sup>e</sup>General Health Questionnaire&#8212;12 Item</p></table-wrap-foot></table-wrap><xref rid="Tab7" ref-type="table">7</xref>).</p></sec><sec id="Sec20"><title>Appendix 4</title><p id="Par44">(See Table <table-wrap id="Tab8" position="float" orientation="portrait"><label>Table 8</label><caption><p>Health services utilisation and medication dispensation item totals and extended summary statistics among PATH participants (N&#8201;=&#8201;255)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Outcome</th><th align="left" colspan="1" rowspan="1">Total items</th><th align="left" colspan="1" rowspan="1">At least one contact or dispensation</th><th align="left" colspan="1" rowspan="1">Mean</th><th align="left" colspan="1" rowspan="1">Variance</th><th align="left" colspan="1" rowspan="1">SD<sup>a</sup></th><th align="left" colspan="1" rowspan="1">Min</th><th align="left" colspan="1" rowspan="1">Q1<sup>b</sup></th><th align="left" colspan="1" rowspan="1">Median</th><th align="left" colspan="1" rowspan="1">Q3<sup>c</sup></th><th align="left" colspan="1" rowspan="1">Max</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">GP: Standard</td><td char="." align="char" colspan="1" rowspan="1">697</td><td char="." align="char" colspan="1" rowspan="1">172</td><td char="." align="char" colspan="1" rowspan="1">2.73</td><td char="." align="char" colspan="1" rowspan="1">13.47</td><td char="." align="char" colspan="1" rowspan="1">3.67</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">30</td></tr><tr><td align="left" colspan="1" rowspan="1">GP: Extended</td><td char="." align="char" colspan="1" rowspan="1">194</td><td char="." align="char" colspan="1" rowspan="1">102</td><td char="." align="char" colspan="1" rowspan="1">0.76</td><td char="." align="char" colspan="1" rowspan="1">1.83</td><td char="." align="char" colspan="1" rowspan="1">1.35</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">10</td></tr><tr><td align="left" colspan="1" rowspan="1">GP: Mental health</td><td char="." align="char" colspan="1" rowspan="1">136</td><td char="." align="char" colspan="1" rowspan="1">82</td><td char="." align="char" colspan="1" rowspan="1">0.53</td><td char="." align="char" colspan="1" rowspan="1">1.28</td><td char="." align="char" colspan="1" rowspan="1">1.13</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">7</td></tr><tr><td align="left" colspan="1" rowspan="1">GP: After-hours</td><td char="." align="char" colspan="1" rowspan="1">86</td><td char="." align="char" colspan="1" rowspan="1">42</td><td char="." align="char" colspan="1" rowspan="1">0.34</td><td char="." align="char" colspan="1" rowspan="1">1.18</td><td char="." align="char" colspan="1" rowspan="1">1.08</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">9</td></tr><tr><td align="left" colspan="1" rowspan="1">Pathology</td><td char="." align="char" colspan="1" rowspan="1">353</td><td char="." align="char" colspan="1" rowspan="1">62</td><td char="." align="char" colspan="1" rowspan="1">1.38</td><td char="." align="char" colspan="1" rowspan="1">10.07</td><td char="." align="char" colspan="1" rowspan="1">3.17</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">26</td></tr><tr><td align="left" colspan="1" rowspan="1">Total scripts</td><td char="." align="char" colspan="1" rowspan="1">1188</td><td char="." align="char" colspan="1" rowspan="1">159</td><td char="." align="char" colspan="1" rowspan="1">4.66</td><td char="." align="char" colspan="1" rowspan="1">61.43</td><td char="." align="char" colspan="1" rowspan="1">7.84</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">49</td></tr><tr><td align="left" colspan="1" rowspan="1">ATC: Nervous System</td><td char="." align="char" colspan="1" rowspan="1">894</td><td char="." align="char" colspan="1" rowspan="1">140</td><td char="." align="char" colspan="1" rowspan="1">3.51</td><td char="." align="char" colspan="1" rowspan="1">46.50</td><td char="." align="char" colspan="1" rowspan="1">6.82</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">49</td></tr><tr><td align="left" colspan="1" rowspan="1">ATC: Anti-infectives</td><td char="." align="char" colspan="1" rowspan="1">103</td><td char="." align="char" colspan="1" rowspan="1">57</td><td char="." align="char" colspan="1" rowspan="1">0.40</td><td char="." align="char" colspan="1" rowspan="1">1.62</td><td char="." align="char" colspan="1" rowspan="1">1.27</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">15</td></tr><tr><td align="left" colspan="1" rowspan="1">ATC: Alimentary &amp; metabolic</td><td char="." align="char" colspan="1" rowspan="1">64</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">0.25</td><td char="." align="char" colspan="1" rowspan="1">1.01</td><td char="." align="char" colspan="1" rowspan="1">1.00</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">11</td></tr><tr><td align="left" colspan="1" rowspan="1">ATC: Other</td><td char="." align="char" colspan="1" rowspan="1">127</td><td char="." align="char" colspan="1" rowspan="1">41</td><td char="." align="char" colspan="1" rowspan="1">0.50</td><td char="." align="char" colspan="1" rowspan="1">2.37</td><td char="." align="char" colspan="1" rowspan="1">1.54</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">10</td></tr><tr><td align="left" colspan="1" rowspan="1">Opioids</td><td char="." align="char" colspan="1" rowspan="1">125</td><td char="." align="char" colspan="1" rowspan="1">39</td><td char="." align="char" colspan="1" rowspan="1">0.49</td><td char="." align="char" colspan="1" rowspan="1">3.11</td><td char="." align="char" colspan="1" rowspan="1">1.76</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">17</td></tr><tr><td align="left" colspan="1" rowspan="1">Benzodiazepines</td><td char="." align="char" colspan="1" rowspan="1">353</td><td char="." align="char" colspan="1" rowspan="1">56</td><td char="." align="char" colspan="1" rowspan="1">1.38</td><td char="." align="char" colspan="1" rowspan="1">22.84</td><td char="." align="char" colspan="1" rowspan="1">4.78</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">45</td></tr><tr><td align="left" colspan="1" rowspan="1">Gabapentinoids</td><td char="." align="char" colspan="1" rowspan="1">114</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">0.45</td><td char="." align="char" colspan="1" rowspan="1">3.00</td><td char="." align="char" colspan="1" rowspan="1">1.73</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">14</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Standard deviation, <sup>b</sup>25th percentile, <sup>c</sup>75th percentile</p></table-wrap-foot></table-wrap><xref rid="Tab8" ref-type="table">8</xref>).</p></sec><sec id="Sec21"><title>Appendix 5</title><p id="Par45">(See Table <table-wrap id="Tab9" position="float" orientation="portrait"><label>Table 9</label><caption><p>Participants (<italic toggle="yes">N</italic>&#8201;=&#8201;255), total outcome counts (between date of index release and three-month follow-up), outcome counts stratified by model covariates and results of generalised linear models for health service outcomes, reported as adjusted incidence rate ratios (AIRR)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="1" rowspan="1">Participants (<italic toggle="yes">N</italic>&#8201;=&#8201;255)</th><th align="left" colspan="2" rowspan="1">1. Standard consultations (<italic toggle="yes">n</italic>&#8201;=&#8201;697)</th><th align="left" colspan="2" rowspan="1">2. Extended consultations (<italic toggle="yes">n</italic>&#8201;=&#8201;194)</th><th align="left" colspan="2" rowspan="1">3. Mental health consultations (<italic toggle="yes">n</italic>&#8201;=&#8201;136)</th><th align="left" colspan="2" rowspan="1">4. After-hours consultations (<italic toggle="yes">n</italic>&#8201;=&#8201;86)</th><th align="left" colspan="2" rowspan="1">5. Pathology items (<italic toggle="yes">n</italic>&#8201;=&#8201;353)</th></tr><tr><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Post-release OAT use</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">148 (58)</td><td align="left" colspan="1" rowspan="1">227 (33)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">82 (42)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">57 (42)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">29 (34)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">153 (43)</td><td align="left" colspan="1" rowspan="1">REF</td></tr><tr><td align="left" colspan="1" rowspan="1">Interrupted</td><td align="left" colspan="1" rowspan="1">32 (13)</td><td align="left" colspan="1" rowspan="1">127 (18)</td><td align="left" colspan="1" rowspan="1">3.02 (1.88&#8211;4.86)</td><td align="left" colspan="1" rowspan="1">33 (17)</td><td align="left" colspan="1" rowspan="1">2.56 (1.41&#8211;4.67)</td><td align="left" colspan="1" rowspan="1">27 (20)</td><td align="left" colspan="1" rowspan="1">2.71 (1.42&#8211;5.20)</td><td align="left" colspan="1" rowspan="1">26 (30)</td><td align="left" colspan="1" rowspan="1">4.61 (2.24&#8211;9.48)</td><td align="left" colspan="1" rowspan="1">37 (10)</td><td align="left" colspan="1" rowspan="1">1.26 (0.71&#8211;2.23)</td></tr><tr><td align="left" colspan="1" rowspan="1">Complete</td><td align="left" colspan="1" rowspan="1">75 (29)</td><td align="left" colspan="1" rowspan="1">343 (49)</td><td align="left" colspan="1" rowspan="1">3.66 (2.57&#8211;5.23)</td><td align="left" colspan="1" rowspan="1">79 (41)</td><td align="left" colspan="1" rowspan="1">2.55 (1.60&#8211;4.07)</td><td align="left" colspan="1" rowspan="1">52 (38)</td><td align="left" colspan="1" rowspan="1">2.27 (1.33&#8211;3.87)</td><td align="left" colspan="1" rowspan="1">31 (36)</td><td align="left" colspan="1" rowspan="1">1.56 (0.78&#8211;3.10)</td><td align="left" colspan="1" rowspan="1">163 (46)</td><td align="left" colspan="1" rowspan="1">2.30 (1.52&#8211;3.48)</td></tr><tr><td align="left" colspan="1" rowspan="1">Age (mean, [SD<sup>a</sup>])</td><td align="left" colspan="1" rowspan="1">36 (8)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.03 (1.01&#8211;1.05)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.04 (1.01&#8211;1.07)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.03 (1.00&#8211;1.06)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.00 (0.97&#8211;1.04)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.06 (1.03&#8211;1.08)</td></tr><tr><td align="left" colspan="1" rowspan="1">Aboriginal and/or Torres Strait Islander</td><td align="left" colspan="1" rowspan="1">40 (16)</td><td align="left" colspan="1" rowspan="1">70 (10)</td><td align="left" colspan="1" rowspan="1">0.70 (0.43&#8211;1.13)</td><td align="left" colspan="1" rowspan="1">26 (13)</td><td align="left" colspan="1" rowspan="1">0.80 (0.44&#8211;1.47)</td><td align="left" colspan="1" rowspan="1">12 (9)</td><td align="left" colspan="1" rowspan="1">0.67 (0.32&#8211;1.42)</td><td align="left" colspan="1" rowspan="1">7 (8)</td><td align="left" colspan="1" rowspan="1">0.78 (0.30&#8211;2.03)</td><td align="left" colspan="1" rowspan="1">41 (12)</td><td align="left" colspan="1" rowspan="1">0.73 (0.42&#8211;1.25)</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported fair or poor health</td><td align="left" colspan="1" rowspan="1">75 (29)</td><td align="left" colspan="1" rowspan="1">223 (32)</td><td align="left" colspan="1" rowspan="1">1.59 (1.07&#8211;2.36)</td><td align="left" colspan="1" rowspan="1">72 (37)</td><td align="left" colspan="1" rowspan="1">1.30 (0.80&#8211;2.13)</td><td align="left" colspan="1" rowspan="1">39 (29)</td><td align="left" colspan="1" rowspan="1">0.76 (0.43&#8211;1.34)</td><td align="left" colspan="1" rowspan="1">26 (30)</td><td align="left" colspan="1" rowspan="1">1.05 (0.51&#8211;2.15)</td><td align="left" colspan="1" rowspan="1">133 (38)</td><td align="left" colspan="1" rowspan="1">1.26 (0.82&#8211;1.94)</td></tr><tr><td align="left" colspan="1" rowspan="1">GHQ-12 Score</td><td align="left" colspan="1" rowspan="1">3 (1&#8211;6)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.98 (0.93&#8211;1.03)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.99 (0.92&#8211;1.06)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.04 (0.96&#8211;1.13)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.07 (0.97&#8211;1.17)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.98 (0.92&#8211;1.05)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Area of residence</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Metro</td><td align="left" colspan="1" rowspan="1">129 (51)</td><td align="left" colspan="1" rowspan="1">394 (57)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">103 (53)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">82 (60)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">57 (66)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">205 (58)</td><td align="left" colspan="1" rowspan="1">REF</td></tr><tr><td align="left" colspan="1" rowspan="1">Regional</td><td align="left" colspan="1" rowspan="1">84 (33)</td><td align="left" colspan="1" rowspan="1">195 (28)</td><td align="left" colspan="1" rowspan="1">0.78 (0.54&#8211;1.15)</td><td align="left" colspan="1" rowspan="1">68 (35)</td><td align="left" colspan="1" rowspan="1">0.98 (0.60&#8211;1.58)</td><td align="left" colspan="1" rowspan="1">34 (25)</td><td align="left" colspan="1" rowspan="1">0.58 (0.34&#8211;1.01)</td><td align="left" colspan="1" rowspan="1">11 (13)</td><td align="left" colspan="1" rowspan="1">0.31 (0.14&#8211;0.68)</td><td align="left" colspan="1" rowspan="1">120 (34)</td><td align="left" colspan="1" rowspan="1">0.89 (0.58&#8211;1.36)</td></tr><tr><td align="left" colspan="1" rowspan="1">Prison/other</td><td align="left" colspan="1" rowspan="1">42 (16)</td><td align="left" colspan="1" rowspan="1">108 (15)</td><td align="left" colspan="1" rowspan="1">1.07 (0.64&#8211;1.79)</td><td align="left" colspan="1" rowspan="1">23 (12)</td><td align="left" colspan="1" rowspan="1">0.80 (0.40&#8211;1.60)</td><td align="left" colspan="1" rowspan="1">20 (15)</td><td align="left" colspan="1" rowspan="1">0.69 (0.32&#8211;1.47)</td><td align="left" colspan="1" rowspan="1">18 (21)</td><td align="left" colspan="1" rowspan="1">0.60 (0.24&#8211;1.52)</td><td align="left" colspan="1" rowspan="1">28 (8)</td><td align="left" colspan="1" rowspan="1">0.60 (0.32&#8211;1.13)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Main drug injected in the last 30&#160;days</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Heroin</td><td align="left" colspan="1" rowspan="1">32 (13)</td><td align="left" colspan="1" rowspan="1">103 (15)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">31 (16)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">20 (15)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">12 (14)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">55 (16)</td><td align="left" colspan="1" rowspan="1">REF</td></tr><tr><td align="left" colspan="1" rowspan="1">Methamphetamine</td><td align="left" colspan="1" rowspan="1">72 (28)</td><td align="left" colspan="1" rowspan="1">139 (20)</td><td align="left" colspan="1" rowspan="1">1.14 (0.65&#8211;1.99)</td><td align="left" colspan="1" rowspan="1">44 (23)</td><td align="left" colspan="1" rowspan="1">1.09 (0.52&#8211;2.26)</td><td align="left" colspan="1" rowspan="1">33 (24)</td><td align="left" colspan="1" rowspan="1">1.23 (0.55&#8211;2.73)</td><td align="left" colspan="1" rowspan="1">12 (14)</td><td align="left" colspan="1" rowspan="1">0.58 (0.20&#8211;1.66)</td><td align="left" colspan="1" rowspan="1">51 (14)</td><td align="left" colspan="1" rowspan="1">0.99 (0.51&#8211;1.91)</td></tr><tr><td align="left" colspan="1" rowspan="1">Methamphetamine and Heroin</td><td align="left" colspan="1" rowspan="1">53 (21)</td><td align="left" colspan="1" rowspan="1">151 (22)</td><td align="left" colspan="1" rowspan="1">1.38 (0.79&#8211;2.40)</td><td align="left" colspan="1" rowspan="1">31 (16)</td><td align="left" colspan="1" rowspan="1">0.82 (0.40&#8211;1.71)</td><td align="left" colspan="1" rowspan="1">17 (13)</td><td align="left" colspan="1" rowspan="1">0.72 (0.31&#8211;1.66)</td><td align="left" colspan="1" rowspan="1">10 (12)</td><td align="left" colspan="1" rowspan="1">0.41 (0.14&#8211;1.21)</td><td align="left" colspan="1" rowspan="1">73 (21)</td><td align="left" colspan="1" rowspan="1">1.67 (0.90&#8211;3.11)</td></tr><tr><td align="left" colspan="1" rowspan="1">No heroin or methamphetamine</td><td align="left" colspan="1" rowspan="1">98 (38)</td><td align="left" colspan="1" rowspan="1">304 (44)</td><td align="left" colspan="1" rowspan="1">1.69 (1.00&#8211;2.87)</td><td align="left" colspan="1" rowspan="1">88 (45)</td><td align="left" colspan="1" rowspan="1">1.74 (0.88&#8211;3.42)</td><td align="left" colspan="1" rowspan="1">66 (49)</td><td align="left" colspan="1" rowspan="1">2.05 (0.99&#8211;4.27)</td><td align="left" colspan="1" rowspan="1">52 (60)</td><td align="left" colspan="1" rowspan="1">1.95 (0.80&#8211;4.78)</td><td align="left" colspan="1" rowspan="1">174 (49)</td><td align="left" colspan="1" rowspan="1">2.53 (1.40&#8211;4.56)</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported lifetime chronic health condition</td><td align="left" colspan="1" rowspan="1">170 (67)</td><td align="left" colspan="1" rowspan="1">458 (66)</td><td align="left" colspan="1" rowspan="1">0.81 (0.58&#8211;1.15)</td><td align="left" colspan="1" rowspan="1">144 (74)</td><td align="left" colspan="1" rowspan="1">1.17 (0.73&#8211;1.88)</td><td align="left" colspan="1" rowspan="1">95 (70)</td><td align="left" colspan="1" rowspan="1">1.11 (0.66&#8211;1.88)</td><td align="left" colspan="1" rowspan="1">66 (77)</td><td align="left" colspan="1" rowspan="1">1.47 (0.74&#8211;2.93)</td><td align="left" colspan="1" rowspan="1">249 (71)</td><td align="left" colspan="1" rowspan="1">0.93 (0.62&#8211;1.38)</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported lifetime mental health condition</td><td align="left" colspan="1" rowspan="1">213 (84)</td><td align="left" colspan="1" rowspan="1">585 (84)</td><td align="left" colspan="1" rowspan="1">1.15 (0.74&#8211;1.79)</td><td align="left" colspan="1" rowspan="1">177 (91)</td><td align="left" colspan="1" rowspan="1">2.04 (1.07&#8211;3.90)</td><td align="left" colspan="1" rowspan="1">121 (89)</td><td align="left" colspan="1" rowspan="1">1.64 (0.83&#8211;3.27)</td><td align="left" colspan="1" rowspan="1">75 (87)</td><td align="left" colspan="1" rowspan="1">1.18 (0.52&#8211;2.65)</td><td align="left" colspan="1" rowspan="1">308 (87)</td><td align="left" colspan="1" rowspan="1">1.51 (0.90&#8211;2.56)</td></tr><tr><td align="left" colspan="1" rowspan="1">Times moved since last interview (median, [IQR<sup>b</sup>])</td><td align="left" colspan="1" rowspan="1">1 (0&#8211;3)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.91 (0.72&#8211;1.15)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.11 (0.83&#8211;1.50)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.94 (0.67&#8211;1.33)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.21 (0.79&#8211;1.86)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.07 (0.82&#8211;1.39)</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported unstable accommodation</td><td align="left" colspan="1" rowspan="1">40 (16)</td><td align="left" colspan="1" rowspan="1">108 (15)</td><td align="left" colspan="1" rowspan="1">0.84 (0.49&#8211;1.44)</td><td align="left" colspan="1" rowspan="1">40 (21)</td><td align="left" colspan="1" rowspan="1">0.94 (0.47&#8211;1.88)</td><td align="left" colspan="1" rowspan="1">21 (15)</td><td align="left" colspan="1" rowspan="1">0.83 (0.37&#8211;1.89)</td><td align="left" colspan="1" rowspan="1">24 (28)</td><td align="left" colspan="1" rowspan="1">1.24 (0.50&#8211;3.06)</td><td align="left" colspan="1" rowspan="1">53 (15)</td><td align="left" colspan="1" rowspan="1">0.80 (0.43&#8211;1.47)</td></tr><tr><td align="left" colspan="1" rowspan="1">Current support worker</td><td align="left" colspan="1" rowspan="1">72 (28)</td><td align="left" colspan="1" rowspan="1">261 (37)</td><td align="left" colspan="1" rowspan="1">1.78 (1.25&#8211;2.52)</td><td align="left" colspan="1" rowspan="1">75 (39)</td><td align="left" colspan="1" rowspan="1">1.35 (0.85&#8211;2.13)</td><td align="left" colspan="1" rowspan="1">56 (41)</td><td align="left" colspan="1" rowspan="1">1.82 (1.11&#8211;3.00)</td><td align="left" colspan="1" rowspan="1">27 (31)</td><td align="left" colspan="1" rowspan="1">0.98 (0.52&#8211;1.85)</td><td align="left" colspan="1" rowspan="1">104 (29)</td><td align="left" colspan="1" rowspan="1">1.01 (0.67&#8211;1.52)</td></tr><tr><td align="left" colspan="1" rowspan="1">Model constant</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.01)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.01)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Standard deviation; <sup>b</sup>Interquartile range</p></table-wrap-foot></table-wrap><xref rid="Tab9" ref-type="table">9</xref>).</p></sec><sec id="Sec22"><title>Appendix 6</title><p id="Par46">(See Table <table-wrap id="Tab10" position="float" orientation="portrait"><label>Table 10</label><caption><p>Participants (<italic toggle="yes">N</italic>&#8201;=&#8201;255), total outcome counts (between date of index release and three-month follow-up), outcome counts stratified by model covariates and results of generalised linear models for each prescription medication outcome, reported as adjusted incidence rate ratios (AIRR)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="1" rowspan="1">Participants (<italic toggle="yes">N</italic>&#8201;=&#8201;255)</th><th align="left" colspan="2" rowspan="1">6. Total Dispensation s(<italic toggle="yes">n</italic>&#8201;=&#8201;1188)</th><th align="left" colspan="2" rowspan="1">7. ATC: Nervous system (<italic toggle="yes">n</italic>&#8201;=&#8201;894)</th><th align="left" colspan="2" rowspan="1">8. ATC: Anti-infectives (<italic toggle="yes">n</italic>&#8201;=&#8201;103)</th><th align="left" colspan="2" rowspan="1">9. ATC: Alimentary &amp; Metabolic (<italic toggle="yes">n</italic>&#8201;=&#8201;64)</th></tr><tr><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Post-release OAT use</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">148 (58)</td><td align="left" colspan="1" rowspan="1">548 (46)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">338 (38)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">79 (77)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">41 (64)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Interrupted</td><td align="left" colspan="1" rowspan="1">32 (13)</td><td align="left" colspan="1" rowspan="1">155 (13)</td><td align="left" colspan="1" rowspan="1">1.88 (1.19&#8211;2.98)</td><td align="left" colspan="1" rowspan="1">135 (15)</td><td align="left" colspan="1" rowspan="1">2.59 (1.61&#8211;4.16)</td><td align="left" colspan="1" rowspan="1">9 (9)</td><td align="left" colspan="1" rowspan="1">0.78 (0.33&#8211;1.83)</td><td align="left" colspan="1" rowspan="1">np<sup>a</sup></td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Complete</td><td align="left" colspan="1" rowspan="1">75 (29)</td><td align="left" colspan="1" rowspan="1">485 (41)</td><td align="left" colspan="1" rowspan="1">2.40 (1.71&#8211;3.37)</td><td align="left" colspan="1" rowspan="1">421 (47)</td><td align="left" colspan="1" rowspan="1">3.54 (2.48&#8211;5.03)</td><td align="left" colspan="1" rowspan="1">15 (15)</td><td align="left" colspan="1" rowspan="1">0.51 (0.26&#8211;1.00)</td><td align="left" colspan="1" rowspan="1">21 (33)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Age (mean, [SD<sup>b</sup>])</td><td align="left" colspan="1" rowspan="1">36 (8)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.05 (1.03&#8211;1.07)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.05 (1.03&#8211;1.07)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.03 (1.00&#8211;1.06)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Aboriginal and/or Torres Strait Islander</td><td align="left" colspan="1" rowspan="1">40 (16)</td><td align="left" colspan="1" rowspan="1">129 (11)</td><td align="left" colspan="1" rowspan="1">0.53 (0.34&#8211;0.83)</td><td align="left" colspan="1" rowspan="1">92 (10)</td><td align="left" colspan="1" rowspan="1">0.54 (0.33&#8211;0.86)</td><td align="left" colspan="1" rowspan="1">10 (10)</td><td align="left" colspan="1" rowspan="1">0.56 (0.24&#8211;1.27)</td><td align="left" colspan="1" rowspan="1">12 (19)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported fair or poor health</td><td align="left" colspan="1" rowspan="1">75 (29)</td><td align="left" colspan="1" rowspan="1">431 (36)</td><td align="left" colspan="1" rowspan="1">1.61 (1.11&#8211;2.34)</td><td align="left" colspan="1" rowspan="1">310 (35)</td><td align="left" colspan="1" rowspan="1">1.59 (1.07&#8211;2.34)</td><td align="left" colspan="1" rowspan="1">53 (51)</td><td align="left" colspan="1" rowspan="1">1.91 (1.06&#8211;3.45)</td><td align="left" colspan="1" rowspan="1">20 (31)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">GHQ-12 Score</td><td align="left" colspan="1" rowspan="1">3 (1&#8211;6)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.97 (0.92&#8211;1.01)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.99 (0.94&#8211;1.04)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.96 (0.89&#8211;1.05)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Area of residence</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Metro</td><td align="left" colspan="1" rowspan="1">129 (51)</td><td align="left" colspan="1" rowspan="1">628 (53)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">478 (53)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">52 (50)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">36 (56)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Regional</td><td align="left" colspan="1" rowspan="1">84 (33)</td><td align="left" colspan="1" rowspan="1">401 (34)</td><td align="left" colspan="1" rowspan="1">0.99 (0.69&#8211;1.42)</td><td align="left" colspan="1" rowspan="1">281 (31)</td><td align="left" colspan="1" rowspan="1">0.94 (0.64&#8211;1.36)</td><td align="left" colspan="1" rowspan="1">38 (37)</td><td align="left" colspan="1" rowspan="1">1.14 (0.62&#8211;2.10)</td><td align="left" colspan="1" rowspan="1">23 (36)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Prison/other</td><td align="left" colspan="1" rowspan="1">42 (16)</td><td align="left" colspan="1" rowspan="1">159 (13)</td><td align="left" colspan="1" rowspan="1">1.09 (0.68&#8211;1.77)</td><td align="left" colspan="1" rowspan="1">135 (15)</td><td align="left" colspan="1" rowspan="1">1.17 (0.71&#8211;1.93)</td><td align="left" colspan="1" rowspan="1">13 (13)</td><td align="left" colspan="1" rowspan="1">1.42 (0.58&#8211;3.47)</td><td align="left" colspan="1" rowspan="1">5 (8)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Main drug injected in the last 30&#160;days</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Heroin</td><td align="left" colspan="1" rowspan="1">32 (13)</td><td align="left" colspan="1" rowspan="1">137 (12)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">101 (11)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">5 (5)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">14 (22)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Methamphetamine</td><td align="left" colspan="1" rowspan="1">72 (28)</td><td align="left" colspan="1" rowspan="1">272 (23)</td><td align="left" colspan="1" rowspan="1">1.92 (1.12&#8211;3.29)</td><td align="left" colspan="1" rowspan="1">190 (21)</td><td align="left" colspan="1" rowspan="1">1.72 (0.98&#8211;3.03)</td><td align="left" colspan="1" rowspan="1">43 (42)</td><td align="left" colspan="1" rowspan="1">4.59 (1.47&#8211;14.28)</td><td align="left" colspan="1" rowspan="1">6 (9)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Methamphetamine and Heroin</td><td align="left" colspan="1" rowspan="1">53 (21)</td><td align="left" colspan="1" rowspan="1">201 (17)</td><td align="left" colspan="1" rowspan="1">1.66 (0.96&#8211;2.86)</td><td align="left" colspan="1" rowspan="1">160 (18)</td><td align="left" colspan="1" rowspan="1">1.66 (0.94&#8211;2.93)</td><td align="left" colspan="1" rowspan="1">14 (14)</td><td align="left" colspan="1" rowspan="1">2.37 (0.71&#8211;7.91)</td><td align="left" colspan="1" rowspan="1">10 (16)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">No heroin or methamphetamine</td><td align="left" colspan="1" rowspan="1">98 (38)</td><td align="left" colspan="1" rowspan="1">578 (49)</td><td align="left" colspan="1" rowspan="1">2.62 (1.58&#8211;4.36)</td><td align="left" colspan="1" rowspan="1">443 (50)</td><td align="left" colspan="1" rowspan="1">2.62 (1.53&#8211;4.46)</td><td align="left" colspan="1" rowspan="1">41 (40)</td><td align="left" colspan="1" rowspan="1">3.92 (1.28&#8211;11.96)</td><td align="left" colspan="1" rowspan="1">34 (53)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported lifetime chronic health condition</td><td align="left" colspan="1" rowspan="1">170 (67)</td><td align="left" colspan="1" rowspan="1">899 (76)</td><td align="left" colspan="1" rowspan="1">1.19 (0.85&#8211;1.66)</td><td align="left" colspan="1" rowspan="1">646 (72)</td><td align="left" colspan="1" rowspan="1">0.91 (0.64&#8211;1.30)</td><td align="left" colspan="1" rowspan="1">84 (82)</td><td align="left" colspan="1" rowspan="1">1.93 (1.04&#8211;3.58)</td><td align="left" colspan="1" rowspan="1">58 (91)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported lifetime mental health condition</td><td align="left" colspan="1" rowspan="1">213 (84)</td><td align="left" colspan="1" rowspan="1">1053 (89)</td><td align="left" colspan="1" rowspan="1">1.80 (1.16&#8211;2.79)</td><td align="left" colspan="1" rowspan="1">789 (88)</td><td align="left" colspan="1" rowspan="1">2.00 (1.25&#8211;3.21)</td><td align="left" colspan="1" rowspan="1">90 (87)</td><td align="left" colspan="1" rowspan="1">1.05 (0.50&#8211;2.18)</td><td align="left" colspan="1" rowspan="1">56 (88)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Times moved since last interview (median, [IQR<sup>c</sup>])</td><td align="left" colspan="1" rowspan="1">1 (0&#8211;3)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.85 (0.67&#8211;1.08)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.85 (0.66&#8211;1.09)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.95 (0.64&#8211;1.40)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported unstable accommodation</td><td align="left" colspan="1" rowspan="1">40 (16)</td><td align="left" colspan="1" rowspan="1">234 (20)</td><td align="left" colspan="1" rowspan="1">1.34 (0.79&#8211;2.29)</td><td align="left" colspan="1" rowspan="1">183 (20)</td><td align="left" colspan="1" rowspan="1">1.22 (0.70&#8211;2.12)</td><td align="left" colspan="1" rowspan="1">33 (32)</td><td align="left" colspan="1" rowspan="1">2.26 (0.98&#8211;5.20)</td><td align="left" colspan="1" rowspan="1">11 (17)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Current support worker</td><td align="left" colspan="1" rowspan="1">72 (28)</td><td align="left" colspan="1" rowspan="1">503 (42)</td><td align="left" colspan="1" rowspan="1">1.88 (1.35&#8211;2.62)</td><td align="left" colspan="1" rowspan="1">373 (42)</td><td align="left" colspan="1" rowspan="1">2.06 (1.47&#8211;2.91)</td><td align="left" colspan="1" rowspan="1">39 (38)</td><td align="left" colspan="1" rowspan="1">1.52 (0.86&#8211;2.68)</td><td align="left" colspan="1" rowspan="1">37 (58)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Model constant</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8211;</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="2" rowspan="1">10. ATC: Other (<italic toggle="yes">n</italic>&#8201;=&#8201;127)</th><th align="left" colspan="2" rowspan="1">11. Opioids (<italic toggle="yes">n</italic>&#8201;=&#8201;125)</th><th align="left" colspan="2" rowspan="1">12. Benzodiazepines (<italic toggle="yes">n</italic>&#8201;=&#8201;353)</th><th align="left" colspan="2" rowspan="1">13. Gabapentinoids (<italic toggle="yes">n</italic>&#8201;=&#8201;114)</th></tr><tr><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</th><th align="left" colspan="1" rowspan="1">AIRR (95%CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Post-release OAT use</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">90 (71)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">80 (64)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">74 (21)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">28 (25)</td><td align="left" colspan="1" rowspan="1">REF</td></tr><tr><td align="left" colspan="1" rowspan="1">Interrupted</td><td align="left" colspan="1" rowspan="1">9 (7)</td><td align="left" colspan="1" rowspan="1">0.70 (0.29&#8211;1.70)</td><td align="left" colspan="1" rowspan="1">10 (8)</td><td align="left" colspan="1" rowspan="1">0.89 (0.36&#8211;2.21)</td><td align="left" colspan="1" rowspan="1">68 (19)</td><td align="left" colspan="1" rowspan="1">4.99 (2.81&#8211;8.85)</td><td align="left" colspan="1" rowspan="1">33 (29)</td><td align="left" colspan="1" rowspan="1">6.78 (3.34&#8211;13.77)</td></tr><tr><td align="left" colspan="1" rowspan="1">Complete</td><td align="left" colspan="1" rowspan="1">28 (22)</td><td align="left" colspan="1" rowspan="1">0.72 (0.39&#8211;1.33)</td><td align="left" colspan="1" rowspan="1">35 (28)</td><td align="left" colspan="1" rowspan="1">1.08 (0.57&#8211;2.06)</td><td align="left" colspan="1" rowspan="1">211 (60)</td><td align="left" colspan="1" rowspan="1">8.30 (5.28&#8211;13.04)</td><td align="left" colspan="1" rowspan="1">53 (46)</td><td align="left" colspan="1" rowspan="1">4.34 (2.37&#8211;7.94)</td></tr><tr><td align="left" colspan="1" rowspan="1">Age (mean, [SD<sup>b</sup>])</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.09 (1.06&#8211;1.13)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.07 (1.03&#8211;1.10)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.06 (1.03&#8211;1.09)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.03 (0.99&#8211;1.07)</td></tr><tr><td align="left" colspan="1" rowspan="1">Aboriginal and/or Torres Strait Islander</td><td align="left" colspan="1" rowspan="1">15 (12)</td><td align="left" colspan="1" rowspan="1">0.76 (0.34&#8211;1.67)</td><td align="left" colspan="1" rowspan="1">8 (6)</td><td align="left" colspan="1" rowspan="1">0.38 (0.14&#8211;1.05)</td><td align="left" colspan="1" rowspan="1">36 (10)</td><td align="left" colspan="1" rowspan="1">1.02 (0.55&#8211;1.88)</td><td align="left" colspan="1" rowspan="1">14 (12)</td><td align="left" colspan="1" rowspan="1">0.76 (0.33&#8211;1.71)</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported fair or poor health</td><td align="left" colspan="1" rowspan="1">48 (38)</td><td align="left" colspan="1" rowspan="1">1.18 (0.63&#8211;2.22)</td><td align="left" colspan="1" rowspan="1">66 (53)</td><td align="left" colspan="1" rowspan="1">3.11 (1.59&#8211;6.07)</td><td align="left" colspan="1" rowspan="1">95 (27)</td><td align="left" colspan="1" rowspan="1">1.55 (0.94&#8211;2.55)</td><td align="left" colspan="1" rowspan="1">43 (38)</td><td align="left" colspan="1" rowspan="1">1.41 (0.74&#8211;2.69)</td></tr><tr><td align="left" colspan="1" rowspan="1">GHQ-12 Score</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.92 (0.84&#8211;1.01)</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">0.98 (0.90&#8211;1.06)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.95 (0.88&#8211;1.02)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.99 (0.91&#8211;1.07)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Area of residence</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Metro</td><td align="left" colspan="1" rowspan="1">62 (49)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">81 (65)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">178 (50)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">71 (62)</td><td align="left" colspan="1" rowspan="1">REF</td></tr><tr><td align="left" colspan="1" rowspan="1">Regional</td><td align="left" colspan="1" rowspan="1">59 (46)</td><td align="left" colspan="1" rowspan="1">1.24 (0.69&#8211;2.22)</td><td align="left" colspan="1" rowspan="1">38 (30)</td><td align="left" colspan="1" rowspan="1">0.77 (0.42&#8211;1.44)</td><td align="left" colspan="1" rowspan="1">92 (26)</td><td align="left" colspan="1" rowspan="1">0.97 (0.58&#8211;1.62)</td><td align="left" colspan="1" rowspan="1">24 (21)</td><td align="left" colspan="1" rowspan="1">0.56 (0.28&#8211;1.10)</td></tr><tr><td align="left" colspan="1" rowspan="1">Prison/other</td><td align="left" colspan="1" rowspan="1">6 (5)</td><td align="left" colspan="1" rowspan="1">0.43 (0.15&#8211;1.20)</td><td align="left" colspan="1" rowspan="1">6 (5)</td><td align="left" colspan="1" rowspan="1">0.35 (0.11&#8211;1.10)</td><td align="left" colspan="1" rowspan="1">83 (24)</td><td align="left" colspan="1" rowspan="1">1.93 (1.02&#8211;3.66)</td><td align="left" colspan="1" rowspan="1">19 (17)</td><td align="left" colspan="1" rowspan="1">1.66 (0.75&#8211;3.67)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Main drug injected in the last 30&#160;days</italic></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Heroin</td><td align="left" colspan="1" rowspan="1">17 (13)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">27 (22)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">47 (13)</td><td align="left" colspan="1" rowspan="1">REF</td><td align="left" colspan="1" rowspan="1">np<sup>a</sup></td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Methamphetamine</td><td align="left" colspan="1" rowspan="1">33 (26)</td><td align="left" colspan="1" rowspan="1">0.97 (0.39&#8211;2.39)</td><td align="left" colspan="1" rowspan="1">23 (18)</td><td align="left" colspan="1" rowspan="1">0.49 (0.21&#8211;1.17)</td><td align="left" colspan="1" rowspan="1">83 (24)</td><td align="left" colspan="1" rowspan="1">1.70 (0.81&#8211;3.59)</td><td align="left" colspan="1" rowspan="1">12 (11)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Methamphetamine and Heroin</td><td align="left" colspan="1" rowspan="1">17 (13)</td><td align="left" colspan="1" rowspan="1">0.81 (0.32&#8211;2.03)</td><td align="left" colspan="1" rowspan="1">17 (14)</td><td align="left" colspan="1" rowspan="1">0.50 (0.20&#8211;1.26)</td><td align="left" colspan="1" rowspan="1">62 (18)</td><td align="left" colspan="1" rowspan="1">1.28 (0.64&#8211;2.59)</td><td align="left" colspan="1" rowspan="1">16 (14)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">No heroin or methamphetamine</td><td align="left" colspan="1" rowspan="1">60 (47)</td><td align="left" colspan="1" rowspan="1">1.31 (0.57&#8211;3.02)</td><td align="left" colspan="1" rowspan="1">58 (46)</td><td align="left" colspan="1" rowspan="1">1.05 (0.48&#8211;2.27)</td><td align="left" colspan="1" rowspan="1">161 (46)</td><td align="left" colspan="1" rowspan="1">1.53 (0.78&#8211;3.00)</td><td align="left" colspan="1" rowspan="1">85 (75)</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported lifetime chronic health condition</td><td align="left" colspan="1" rowspan="1">111 (87)</td><td align="left" colspan="1" rowspan="1">2.51 (1.30&#8211;4.85)</td><td align="left" colspan="1" rowspan="1">101 (81)</td><td align="left" colspan="1" rowspan="1">1.88 (0.97&#8211;3.66)</td><td align="left" colspan="1" rowspan="1">225 (64)</td><td align="left" colspan="1" rowspan="1">0.77 (0.49&#8211;1.23)</td><td align="left" colspan="1" rowspan="1">96 (84)</td><td align="left" colspan="1" rowspan="1">1.85 (0.93&#8211;3.68)</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported lifetime mental health condition</td><td align="left" colspan="1" rowspan="1">118 (93)</td><td align="left" colspan="1" rowspan="1">3.47 (1.40&#8211;8.60)</td><td align="left" colspan="1" rowspan="1">102 (82)</td><td align="left" colspan="1" rowspan="1">1.15 (0.54&#8211;2.48)</td><td align="left" colspan="1" rowspan="1">291 (82)</td><td align="left" colspan="1" rowspan="1">1.58 (0.87&#8211;2.88)</td><td align="left" colspan="1" rowspan="1">110 (96)</td><td align="left" colspan="1" rowspan="1">5.12 (1.66&#8211;15.73)</td></tr><tr><td align="left" colspan="1" rowspan="1">Times moved since last intervview (median, [IQR<sup>c</sup>])</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.88 (0.59&#8211;1.32)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.95 (0.63&#8211;1.44)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.10 (0.81&#8211;1.51)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.66 (0.43&#8211;1.02)</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported unstable accommodation</td><td align="left" colspan="1" rowspan="1">7 (6)</td><td align="left" colspan="1" rowspan="1">0.35 (0.12&#8211;1.02)</td><td align="left" colspan="1" rowspan="1">9 (7)</td><td align="left" colspan="1" rowspan="1">0.16 (0.05&#8211;0.50)</td><td align="left" colspan="1" rowspan="1">91 (26)</td><td align="left" colspan="1" rowspan="1">2.01 (1.00&#8211;4.04)</td><td align="left" colspan="1" rowspan="1">32 (28)</td><td align="left" colspan="1" rowspan="1">2.10 (0.88&#8211;5.02)</td></tr><tr><td align="left" colspan="1" rowspan="1">Current support worker</td><td align="left" colspan="1" rowspan="1">54 (43)</td><td align="left" colspan="1" rowspan="1">1.08 (0.61&#8211;1.91)</td><td align="left" colspan="1" rowspan="1">69 (55)</td><td align="left" colspan="1" rowspan="1">3.98 (2.34&#8211;6.76)</td><td align="left" colspan="1" rowspan="1">140 (40)</td><td align="left" colspan="1" rowspan="1">1.96 (1.25&#8211;3.08)</td><td align="left" colspan="1" rowspan="1">33 (29)</td><td align="left" colspan="1" rowspan="1">1.03 (0.56&#8211;1.91)</td></tr><tr><td align="left" colspan="1" rowspan="1">Model constant</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.01)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">0.00 (0.00&#8211;0.00)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Not provided due to a small cell size (<italic toggle="yes">n</italic>&#8201;&lt;&#8201;5); <sup>b</sup>Standard deviation; <sup>c</sup>Interquartile range</p></table-wrap-foot></table-wrap><xref rid="Tab10" ref-type="table">10</xref>).</p></sec></app></app-group><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to acknowledge the participants involved in the Prison and Transition Health study for the time and knowledge they contributed to this study. Thanks to the Burnet Institute fieldwork team for their tireless efforts with data collection. We would also like to acknowledge the Victorian Department of Justice and Community Safety, the Australian Institute of Health and Welfare and the Centre for Victorian Data Linkage for the support they have provided.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>MC, with assistance from AW, PD and MS, developed the framework for the paper, undertook statistical analysis and produced the initial draft. ALW, PD, ACS, SAK, RJW, CA, SJW, RDC, TB and MS provided substantial editorial comment and review. MS is the chief investigator of the Prison and Transition Health study and guided paper development and gave editorial support throughout the duration of planning and writing. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The Prison and Transition Health Cohort Study was funded by a NHMRC Project Grant (APP1029915). MC is the recipient of a NHMRC post-graduate award&#160;(APP1168954) and a Monash Addiction Research Centre PhD top-up scholarship. PD and MS are the recipients of NHMRC Senior Research Fellowships. We gratefully acknowledge the support provided to the Burnet Institute by the Victorian Government Operational Infrastructure Support Program.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets analysed during this study are not publically available due to restrictions regarding the sharing of data for people involved with the criminal justice system in Victoria, Australia, but may be available upon request subject relevant ethics approvals.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par38">Ethics approvals for the Prison and Transition Health Cohort Study were obtained from the Alfred Hospital Ethics Committee (79/12) DJCS (CF/14/10169) and AIHW Ethics Committee (EO2014/1/77). All study participants provided consent.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par39">All study participants provided consent.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par40">PD has received investigator-driven funding from Gilead Sciences for work related to hepatitis C treatment and an untied educational grant from Indivior for work related to the introduction of buprenorphine/naloxone into Australia. He has also served as an unpaid member of an Advisory Board for an intranasal naloxone product. The remaining authors declare that they have no conflicts of interest. MS has received investigator-initiated funding from Gilead Sciences, AbbVie and Bristol Myers Squibb, and consultant fees from Gilead Sciences for activities unrelated to this work.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fazel</surname><given-names>S</given-names></name><name name-style="western"><surname>Baillargeon</surname><given-names>J</given-names></name></person-group><article-title>The health of prisoners</article-title><source>Lancet</source><year>2011</year><volume>377</volume><issue>9769</issue><fpage>956</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61053-7</pub-id><pub-id pub-id-type="pmid">21093904</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinner</surname><given-names>SA</given-names></name><name name-style="western"><surname>Young</surname><given-names>JT</given-names></name></person-group><article-title>Understanding and improving the health of people who experience incarceration: an overview and synthesis</article-title><source>Epidemiol Rev</source><year>2018</year><volume>40</volume><issue>1</issue><fpage>4</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1093/epirev/mxx018</pub-id><pub-id pub-id-type="pmid">29860342</pub-id><pub-id pub-id-type="pmcid">PMC5982728</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fazel</surname><given-names>S</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>IA</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>AJ</given-names></name></person-group><article-title>Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women</article-title><source>Addiction</source><year>2017</year><volume>112</volume><issue>10</issue><fpage>1725</fpage><lpage>1739</lpage><pub-id pub-id-type="doi">10.1111/add.13877</pub-id><pub-id pub-id-type="pmid">28543749</pub-id><pub-id pub-id-type="pmcid">PMC5589068</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fazel</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mental health of prisoners: prevalence, adverse outcomes, and interventions</article-title><source>Lancet Psychiatry</source><year>2016</year><volume>3</volume><issue>9</issue><fpage>871</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1016/S2215-0366(16)30142-0</pub-id><pub-id pub-id-type="pmid">27426440</pub-id><pub-id pub-id-type="pmcid">PMC5008459</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Australian Institute of Health and Welfare, The health of Australia's prisoners 2018. 2019, Australian Institute of Health and Welfare: Canberra.</mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larney</surname><given-names>S</given-names></name><etal/></person-group><article-title>Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis</article-title><source>Hepatology</source><year>2013</year><volume>58</volume><issue>4</issue><fpage>1215</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1002/hep.26387</pub-id><pub-id pub-id-type="pmid">23504650</pub-id><pub-id pub-id-type="pmcid">PMC3723697</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolan</surname><given-names>K</given-names></name><etal/></person-group><article-title>People who inject drugs in prison: HIV prevalence, transmission and prevention</article-title><source>Int J Drug Policy</source><year>2015</year><volume>26</volume><issue>Suppl 1</issue><fpage>S12</fpage><lpage>S15</lpage><pub-id pub-id-type="doi">10.1016/j.drugpo.2014.10.012</pub-id><pub-id pub-id-type="pmid">25727258</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baldry</surname><given-names>E</given-names></name><etal/></person-group><article-title>Ex-prisoners, homelessness and the state in Australia</article-title><source>Aust N Z J Criminol</source><year>2016</year><volume>39</volume><issue>1</issue><fpage>20</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1375/acri.39.1.20</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>D</given-names></name><etal/></person-group><article-title>Examining the role of familial support during prison and after release on post-incarceration mental health</article-title><source>Int J Offender Ther Comp Criminol</source><year>2016</year><volume>60</volume><issue>1</issue><fpage>3</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1177/0306624X14548023</pub-id><pub-id pub-id-type="pmid">25156422</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winter</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Resumption of injecting drug use following release from prison in Australia</article-title><source>Drug Alcohol Depend</source><year>2016</year><volume>168</volume><fpage>104</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2016.08.640</pub-id><pub-id pub-id-type="pmid">27635997</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>A</given-names></name><etal/></person-group><article-title>Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study</article-title><source>Addict Sci Clin Pract</source><year>2019</year><volume>14</volume><issue>1</issue><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/s13722-019-0136-6</pub-id><pub-id pub-id-type="pmid">30782211</pub-id><pub-id pub-id-type="pmcid">PMC6381679</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curtis</surname><given-names>M</given-names></name><etal/></person-group><article-title>High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment</article-title><source>Addiction</source><year>2022</year><volume>117</volume><issue>11</issue><fpage>2887</fpage><lpage>2898</lpage><pub-id pub-id-type="doi">10.1111/add.15971</pub-id><pub-id pub-id-type="pmid">35665554</pub-id><pub-id pub-id-type="pmcid">PMC9796148</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Western</surname><given-names>B</given-names></name><etal/></person-group><article-title>Stress and hardship after prison</article-title><source>Am J Sociol</source><year>2015</year><volume>120</volume><issue>5</issue><fpage>1512</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.1086/681301</pub-id><pub-id pub-id-type="pmid">26421345</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>AC</given-names></name><etal/></person-group><article-title>The prison and transition health (PATH) cohort study: prevalence of health, social, and crime characteristics after release from prison for men reporting a history of injecting drug use in Victoria Australia</article-title><source>Drug Alcohol Depend</source><year>2021</year><volume>227</volume><fpage>108970</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108970</pub-id><pub-id pub-id-type="pmid">34488074</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visher</surname><given-names>CA</given-names></name><name name-style="western"><surname>Debus-Sherrill</surname><given-names>SA</given-names></name><name name-style="western"><surname>Yahner</surname><given-names>J</given-names></name></person-group><article-title>Employment after prison: a longitudinal study of former prisoners</article-title><source>Justice Q</source><year>2010</year><volume>28</volume><issue>5</issue><fpage>698</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1080/07418825.2010.535553</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schroeder</surname><given-names>SE</given-names></name><etal/></person-group><article-title>"It's a revolving door": ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success</article-title><source>Int J Drug Policy</source><year>2022</year><volume>101</volume><fpage>103571</fpage><pub-id pub-id-type="doi">10.1016/j.drugpo.2021.103571</pub-id><pub-id pub-id-type="pmid">35007877</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denton</surname><given-names>M</given-names></name><name name-style="western"><surname>Foster</surname><given-names>M</given-names></name><name name-style="western"><surname>Bland</surname><given-names>R</given-names></name></person-group><article-title>How the prison-to-community transition risk environment influences the experience of men with co-occurring mental health and substance use disorder</article-title><source>Aust N Z J Criminol</source><year>2016</year><volume>50</volume><issue>1</issue><fpage>39</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1177/0004865815620703</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinkley-Rubinstein</surname><given-names>L</given-names></name></person-group><article-title>Incarceration as a catalyst for worsening health</article-title><source>Health Justice</source><year>2013</year><volume>1</volume><issue>1</issue><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/2194-7899-1-3</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spittal</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Suicide in adults released from prison in Queensland, Australia: a cohort study</article-title><source>J Epidemiol Community Health</source><year>2014</year><volume>68</volume><issue>10</issue><fpage>993</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1136/jech-2014-204295</pub-id><pub-id pub-id-type="pmid">25009152</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merrall</surname><given-names>EL</given-names></name><etal/></person-group><article-title>Meta-analysis of drug-related deaths soon after release from prison</article-title><source>Addiction</source><year>2010</year><volume>105</volume><issue>9</issue><fpage>1545</fpage><lpage>1554</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.02990.x</pub-id><pub-id pub-id-type="pmid">20579009</pub-id><pub-id pub-id-type="pmcid">PMC2955973</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bukten</surname><given-names>A</given-names></name><etal/></person-group><article-title>High risk of overdose death following release from prison: variations in mortality during a 15-year observation period</article-title><source>Addiction</source><year>2017</year><volume>112</volume><issue>8</issue><fpage>1432</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1111/add.13803</pub-id><pub-id pub-id-type="pmid">28319291</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinner</surname><given-names>SA</given-names></name><name name-style="western"><surname>Young</surname><given-names>JT</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>M</given-names></name></person-group><article-title>The pivotal role of primary care in meeting the health needs of people recently released from prison</article-title><source>Australas Psychiatry</source><year>2015</year><volume>23</volume><issue>6</issue><fpage>650</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1177/1039856215613008</pub-id><pub-id pub-id-type="pmid">26498149</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Andrade</surname><given-names>DF</given-names></name><etal/></person-group><article-title>Emergency health service contact and reincarceration after release from prison: a prospective cohort study</article-title><source>Crim Behav Ment Health</source><year>2019</year><volume>29</volume><issue>2</issue><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1002/cbm.2106</pub-id><pub-id pub-id-type="pmid">30697841</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carroll</surname><given-names>M</given-names></name><etal/></person-group><article-title>High rates of general practice attendance by former prisoners: a prospective cohort study</article-title><source>Med J Aust</source><year>2017</year><volume>207</volume><issue>2</issue><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.5694/mja16.00841</pub-id><pub-id pub-id-type="pmid">28701128</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Early primary care physician contact and health service utilisation in a large sample of recently released ex-prisoners in Australia: prospective cohort study</article-title><source>BMJ Open</source><year>2015</year><volume>5</volume><issue>6</issue><fpage>e008021</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2015-008021</pub-id><pub-id pub-id-type="pmid">26068513</pub-id><pub-id pub-id-type="pmcid">PMC4466622</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Justice Health, Victorian Prison Opioid Substitution Therapy Program Guidelines Department of Justice &amp; Regulation, Editor. 2015, Victorian Government: Melbourne.</mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Department of Health and Human Services, Policy for maintenance pharmacotherapy for opioid dependence, D.o.H.a.H. Services, Editor. 2016, Victorian Government: Melbourne.</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohlman</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Impact of medication-assisted treatment for opioid addiction on medicaid expenditures and health services utilization rates in vermont</article-title><source>J Subst Abuse Treat</source><year>2016</year><volume>67</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2016.05.002</pub-id><pub-id pub-id-type="pmid">27296656</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ronquest</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder</article-title><source>Subst Abuse Rehabil</source><year>2018</year><volume>9</volume><fpage>59</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.2147/SAR.S150253</pub-id><pub-id pub-id-type="pmid">30310349</pub-id><pub-id pub-id-type="pmcid">PMC6165853</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>A</given-names></name><etal/></person-group><article-title>Healthcare utilization and costs associated with treatment for opioid dependence</article-title><source>J Med Econ</source><year>2018</year><volume>21</volume><issue>4</issue><fpage>406</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1080/13696998.2018.1427101</pub-id><pub-id pub-id-type="pmid">29320915</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spithoff</surname><given-names>S</given-names></name><etal/></person-group><article-title>Quality of primary care among individuals receiving treatment for opioid use disorder</article-title><source>Can Fam Physician</source><year>2019</year><volume>65</volume><issue>5</issue><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">31088874</pub-id><pub-id pub-id-type="pmcid">PMC6516690</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tkacz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients</article-title><source>J Subst Abuse Treat</source><year>2014</year><volume>46</volume><issue>4</issue><fpage>456</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2013.10.014</pub-id><pub-id pub-id-type="pmid">24332511</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baser</surname><given-names>O</given-names></name><etal/></person-group><article-title>Cost and utilization outcomes of opioid-dependence treatments</article-title><source>Am J Manag Care</source><year>2011</year><volume>17</volume><issue>Suppl 8</issue><fpage>S235</fpage><lpage>S248</lpage><pub-id pub-id-type="pmid">21761950</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haddad</surname><given-names>MS</given-names></name><name name-style="western"><surname>Zelenev</surname><given-names>A</given-names></name><name name-style="western"><surname>Altice</surname><given-names>FL</given-names></name></person-group><article-title>Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers</article-title><source>J Urban Health</source><year>2015</year><volume>92</volume><issue>1</issue><fpage>193</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1007/s11524-014-9924-1</pub-id><pub-id pub-id-type="pmid">25550126</pub-id><pub-id pub-id-type="pmcid">PMC4338126</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grebely</surname><given-names>J</given-names></name><etal/></person-group><article-title>Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a systematic review and meta-analysis</article-title><source>Clin Infect Dis</source><year>2021</year><volume>73</volume><issue>1</issue><fpage>e107</fpage><lpage>e118</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa612</pub-id><pub-id pub-id-type="pmid">32447375</pub-id><pub-id pub-id-type="pmcid">PMC8246796</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iversen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Uptake of COVID-19 vaccination among people who inject drugs</article-title><source>Harm Reduct J</source><year>2022</year><volume>19</volume><issue>1</issue><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/s12954-022-00643-3</pub-id><pub-id pub-id-type="pmid">35655217</pub-id><pub-id pub-id-type="pmcid">PMC9162792</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Ward P, Mattick R. Health care utilisation and costs under the Commonwealth Medicare Benefit Scheme by methadone maintenance patients in NSW. In: NDARC Technical Report No. 240. 2005. Sydney: National Drug and Alcohol Research Centre</mixed-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nambiar</surname><given-names>D</given-names></name><name name-style="western"><surname>Stoove</surname><given-names>M</given-names></name><name name-style="western"><surname>Dietze</surname><given-names>P</given-names></name></person-group><article-title>A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs</article-title><source>BMC Health Serv Res</source><year>2014</year><volume>14</volume><fpage>308</fpage><pub-id pub-id-type="doi">10.1186/1472-6963-14-308</pub-id><pub-id pub-id-type="pmid">25030526</pub-id><pub-id pub-id-type="pmcid">PMC4110070</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinner</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Low-intensity case management increases contact with primary care in recently released prisoners: a single-blinded, multisite, randomised controlled trial</article-title><source>J Epidemiol Community Health</source><year>2016</year><volume>70</volume><issue>7</issue><fpage>683</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1136/jech-2015-206565</pub-id><pub-id pub-id-type="pmid">26787201</pub-id><pub-id pub-id-type="pmcid">PMC4941193</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Contact with mental health services after acute care for self-harm among adults released from prison: a prospective data linkage study</article-title><source>Suicide Life Threat Behav</source><year>2020</year><volume>50</volume><issue>5</issue><fpage>990</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1111/sltb.12639</pub-id><pub-id pub-id-type="pmid">32359122</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolan</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection</article-title><source>Addiction</source><year>2005</year><volume>100</volume><issue>6</issue><fpage>820</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2005.01050.x</pub-id><pub-id pub-id-type="pmid">15918812</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Degenhardt</surname><given-names>L</given-names></name><etal/></person-group><article-title>The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study</article-title><source>Addiction</source><year>2014</year><volume>109</volume><issue>8</issue><fpage>1306</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.1111/add.12536</pub-id><pub-id pub-id-type="pmid">24612249</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larney</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration</article-title><source>Addiction</source><year>2012</year><volume>107</volume><issue>2</issue><fpage>372</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2011.03618.x</pub-id><pub-id pub-id-type="pmid">21851442</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howell</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Changes in health services use after receipt of medications for opioid use disorder in a statewide correctional system</article-title><source>Health Aff</source><year>2021</year><volume>40</volume><issue>8</issue><fpage>1304</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.2020.02156</pub-id><pub-id pub-id-type="pmcid">PMC9036835</pub-id><pub-id pub-id-type="pmid">34339247</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Australian Bureau of Statistics. National, state and territory population. 2021; Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/latest-release">https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/latest-release</ext-link>.</mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Australian Bureau of Statistics, Prisoner numbers and prisoner rates by Indigenous Status and sex, States and territories, 2006&#8211;2021 (Tables 40 to 42). 2021. Canberra: Australian Bureau of Statistics</mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Australian Institute of Health and Welfare, National Opioid Pharmacotherapy Statistics Annual Data Collection. 2022. Canberra: AIHW.</mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirwan</surname><given-names>A</given-names></name><etal/></person-group><article-title>The prison and transition health (PATH) cohort study: study protocol and baseline characteristics of a cohort of men with a history of injecting drug use leaving prison in Australia</article-title><source>J Urban Health</source><year>2019</year><volume>96</volume><issue>3</issue><fpage>400</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1007/s11524-019-00353-5</pub-id><pub-id pub-id-type="pmid">30989484</pub-id><pub-id pub-id-type="pmcid">PMC6565648</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Strategies to maximise study retention and limit attrition bias in a prospective cohort study of men reporting a history of injecting drug use released from prison: the prison and transition health study</article-title><source>BMC Med Res Methodol</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>185</fpage><pub-id pub-id-type="doi">10.1186/s12874-021-01380-0</pub-id><pub-id pub-id-type="pmid">34511067</pub-id><pub-id pub-id-type="pmcid">PMC8436457</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tibble</surname><given-names>H</given-names></name><etal/></person-group><article-title>The importance of including aliases in data linkage with vulnerable populations</article-title><source>BMC Med Res Methodol</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/s12874-018-0536-4</pub-id><pub-id pub-id-type="pmid">29980173</pub-id><pub-id pub-id-type="pmcid">PMC6035442</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Department of Health, Medicare Benefits Schedule Book. 2021. Canberra: Commonwealth of Australia</mixed-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mellish</surname><given-names>L</given-names></name><etal/></person-group><article-title>The Australian pharmaceutical benefits scheme data collection: a practical guide for researchers</article-title><source>BMC Res Notes</source><year>2015</year><volume>8</volume><issue>1</issue><fpage>634</fpage><pub-id pub-id-type="doi">10.1186/s13104-015-1616-8</pub-id><pub-id pub-id-type="pmid">26526064</pub-id><pub-id pub-id-type="pmcid">PMC4630883</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Department of Health, PBS Expenditure and prescriptions report 1 July 2020 to 30 June 2021. 2021. Canberra: Department of Health</mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification. 2021; Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/tools/atc-ddd-toolkit/atc-classification">https://www.who.int/tools/atc-ddd-toolkit/atc-classification</ext-link>.</mixed-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forsyth</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study</article-title><source>Addiction</source><year>2018</year><volume>113</volume><issue>5</issue><fpage>937</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1111/add.14106</pub-id><pub-id pub-id-type="pmid">29154395</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>WQ</given-names></name><etal/></person-group><article-title>Risk of overdose-related death for people with a history of incarceration</article-title><source>Addiction</source><year>2021</year><volume>116</volume><issue>6</issue><fpage>1460</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1111/add.15293</pub-id><pub-id pub-id-type="pmid">33047844</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groot</surname><given-names>E</given-names></name><etal/></person-group><article-title>Drug toxicity deaths after release from incarceration in Ontario, 2006&#8211;2013: review of coroner's cases</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>7</issue><fpage>e0157512</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0157512</pub-id><pub-id pub-id-type="pmid">27384044</pub-id><pub-id pub-id-type="pmcid">PMC4934911</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewer</surname><given-names>D</given-names></name><etal/></person-group><article-title>Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis</article-title><source>Addiction</source><year>2020</year><volume>115</volume><issue>6</issue><fpage>1011</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1111/add.14892</pub-id><pub-id pub-id-type="pmid">31705770</pub-id><pub-id pub-id-type="pmcid">PMC7210080</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darke</surname><given-names>S</given-names></name><etal/></person-group><article-title>Health service utilization among heroin users</article-title><source>Addict Disord Treat</source><year>2015</year><volume>14</volume><issue>3</issue><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1097/ADT.0000000000000069</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGrail</surname><given-names>MR</given-names></name><name name-style="western"><surname>Humphreys</surname><given-names>JS</given-names></name></person-group><article-title>Spatial access disparities to primary health care in rural and remote Australia</article-title><source>Geospat Health</source><year>2015</year><volume>10</volume><issue>2</issue><fpage>358</fpage><pub-id pub-id-type="doi">10.4081/gh.2015.358</pub-id><pub-id pub-id-type="pmid">26618314</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="other">Australian Bureau of Statistics. ASGS Coding Indexes (2016). 2016; Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://data.gov.au/data/dataset/asgs-coding-indexes-2016/resource/c6051960-6012-452c-ac68-dba55a1f837a">https://data.gov.au/data/dataset/asgs-coding-indexes-2016/resource/c6051960-6012-452c-ac68-dba55a1f837a</ext-link>.</mixed-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donath</surname><given-names>S</given-names></name></person-group><article-title>The validity of the 12-item general health questionnaire in Australia: a comparison between three scoring methods</article-title><source>Aust N Z J Psychiatry</source><year>2001</year><volume>35</volume><issue>2</issue><fpage>231</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1614.2001.00869.x</pub-id><pub-id pub-id-type="pmid">11284906</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">Goldberg D. General health questionnaire (GHQ-12). 1992; Nfer-Nelson: Windsor</mixed-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>DP</given-names></name><etal/></person-group><article-title>The validity of two versions of the GHQ in the WHO study of mental illness in general health care</article-title><source>Psychol Med</source><year>1997</year><volume>27</volume><issue>1</issue><fpage>191</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1017/S0033291796004242</pub-id><pub-id pub-id-type="pmid">9122299</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plueckhahn</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Are some more equal than others? Challenging the basis for prisoners' exclusion from Medicare</article-title><source>Med J Aust</source><year>2015</year><volume>203</volume><issue>9</issue><fpage>359</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.5694/mja15.00588</pub-id><pub-id pub-id-type="pmid">26510802</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="other">StataCorp, Stata Statistical Software: Release 14. 2015. College Station: StataCorp LP</mixed-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rieckmann</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Treating opioid dependence with buprenorphine in the safety net: critical learning from clinical data</article-title><source>J Behav Health Serv Res</source><year>2017</year><volume>44</volume><issue>3</issue><fpage>351</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1007/s11414-017-9553-z</pub-id><pub-id pub-id-type="pmid">28488155</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>MM</given-names></name><etal/></person-group><article-title>The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature</article-title><source>Int J Drug Policy</source><year>2012</year><volume>23</volume><issue>2</issue><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.drugpo.2011.08.005</pub-id><pub-id pub-id-type="pmid">21996165</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Socias</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Integrated models of care for people who inject drugs and live with hepatitis C virus: a systematic review</article-title><source>Int J Drug Policy</source><year>2019</year><volume>72</volume><fpage>146</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.drugpo.2019.05.023</pub-id><pub-id pub-id-type="pmid">31147142</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calais-Ferreira</surname><given-names>L</given-names></name><etal/></person-group><article-title>Multimorbidity and quality of primary care after release from prison: a prospective data-linkage cohort study</article-title><source>BMC Health Serv Res</source><year>2022</year><volume>22</volume><issue>1</issue><fpage>876</fpage><pub-id pub-id-type="doi">10.1186/s12913-022-08209-6</pub-id><pub-id pub-id-type="pmid">35799190</pub-id><pub-id pub-id-type="pmcid">PMC9264593</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">Medical Board of Australia, Registration Data Table&#8212;June 2021. 2021. Melbourne: Medical Board of Australia</mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Department of Health, Pharmacotherapy training. 2015. Melbourne: Victoria State Government</mixed-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prathivadi</surname><given-names>P</given-names></name><name name-style="western"><surname>Sturgiss</surname><given-names>EA</given-names></name></person-group><article-title>When will opioid agonist therapy become a normal part of comprehensive health care?</article-title><source>Med J Aust</source><year>2021</year><volume>214</volume><issue>11</issue><fpage>504</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.5694/mja2.51095</pub-id><pub-id pub-id-type="pmid">34028044</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whelan</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Remski</surname><given-names>K</given-names></name></person-group><article-title>Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds</article-title><source>J Neurosci Rural Pract</source><year>2012</year><volume>3</volume><issue>1</issue><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.4103/0976-3147.91934</pub-id><pub-id pub-id-type="pmid">22346191</pub-id><pub-id pub-id-type="pmcid">PMC3271614</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattick</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence</article-title><source>Cochrane Database Syst Rev</source><year>2009</year><volume>2009</volume><issue>3</issue><fpage>CD002209</fpage><pub-id pub-id-type="pmid">19588333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD002209.pub2</pub-id><pub-id pub-id-type="pmcid">PMC7097731</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinlock</surname><given-names>TW</given-names></name><etal/></person-group><article-title>A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease</article-title><source>J Subst Abuse Treat</source><year>2009</year><volume>37</volume><issue>3</issue><fpage>277</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2009.03.002</pub-id><pub-id pub-id-type="pmid">19339140</pub-id><pub-id pub-id-type="pmcid">PMC2803487</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinkley-Rubinstein</surname><given-names>L</given-names></name><etal/></person-group><article-title>A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release</article-title><source>Drug Alcohol Depend</source><year>2018</year><volume>184</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2017.11.023</pub-id><pub-id pub-id-type="pmid">29402680</pub-id><pub-id pub-id-type="pmcid">PMC10445765</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curtis</surname><given-names>M</given-names></name><etal/></person-group><article-title>Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: a discrete-time survival analysis</article-title><source>Drug Alcohol Depend</source><year>2023</year><volume>242</volume><fpage>109730</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2022.109730</pub-id><pub-id pub-id-type="pmid">36516552</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shepherd</surname><given-names>A</given-names></name><name name-style="western"><surname>Perrella</surname><given-names>B</given-names></name><name name-style="western"><surname>Hattingh</surname><given-names>HL</given-names></name></person-group><article-title>The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study</article-title><source>Subst Abuse Treat Prev Policy</source><year>2014</year><volume>9</volume><fpage>32</fpage><pub-id pub-id-type="doi">10.1186/1747-597X-9-32</pub-id><pub-id pub-id-type="pmid">25108396</pub-id><pub-id pub-id-type="pmcid">PMC4136401</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Economic analysis of out-of-pocket costs among people in opioid agonist treatment: a cross-sectional survey in three Australian jurisdictions</article-title><source>Int J Drug Policy</source><year>2022</year><volume>99</volume><fpage>103472</fpage><pub-id pub-id-type="doi">10.1016/j.drugpo.2021.103472</pub-id><pub-id pub-id-type="pmid">34649203</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zahra</surname><given-names>E</given-names></name><etal/></person-group><article-title>Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients</article-title><source>Drug Alcohol Rev</source><year>2022</year><volume>41</volume><issue>4</issue><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1111/dar.13437</pub-id><pub-id pub-id-type="pmid">35130368</pub-id><pub-id pub-id-type="pmcid">PMC9398207</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></name><name name-style="western"><surname>Ritter</surname><given-names>A</given-names></name></person-group><article-title>Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system</article-title><source>Drug Alcohol Rev</source><year>2012</year><volume>31</volume><issue>7</issue><fpage>911</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1111/j.1465-3362.2012.00472.x</pub-id><pub-id pub-id-type="pmid">22624529</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haasen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Heroin-assisted treatment for opioid dependence: randomised controlled trial</article-title><source>Br J Psychiatry</source><year>2007</year><volume>191</volume><issue>1</issue><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1192/bjp.bp.106.026112</pub-id><pub-id pub-id-type="pmid">17602126</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanken</surname><given-names>P</given-names></name><etal/></person-group><article-title>Heroin-assisted treatment in the Netherlands: history, findings, and international context</article-title><source>Eur Neuropsychopharmacol</source><year>2010</year><volume>20</volume><issue>Suppl 2</issue><fpage>S105</fpage><lpage>S158</lpage><pub-id pub-id-type="doi">10.1016/S0924-977X(10)70001-8</pub-id><pub-id pub-id-type="pmid">20362236</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>B</given-names></name><etal/></person-group><article-title>Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics</article-title><source>J Urban Health</source><year>2007</year><volume>84</volume><issue>4</issue><fpage>552</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1007/s11524-007-9198-y</pub-id><pub-id pub-id-type="pmid">17562183</pub-id><pub-id pub-id-type="pmcid">PMC2219559</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasan</surname><given-names>MM</given-names></name><etal/></person-group><article-title>A machine learning based two-stage clinical decision support system for predicting patients' discontinuation from opioid use disorder treatment: retrospective observational study</article-title><source>BMC Med Inform Decis Mak</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>331</fpage><pub-id pub-id-type="doi">10.1186/s12911-021-01692-7</pub-id><pub-id pub-id-type="pmid">34836524</pub-id><pub-id pub-id-type="pmcid">PMC8620531</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuman-Olivier</surname><given-names>Z</given-names></name><etal/></person-group><article-title>MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study</article-title><source>Addict Sci Clin Pract</source><year>2018</year><volume>13</volume><issue>1</issue><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/s13722-018-0122-4</pub-id><pub-id pub-id-type="pmid">30249279</pub-id><pub-id pub-id-type="pmcid">PMC6154900</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maricich</surname><given-names>YA</given-names></name><etal/></person-group><article-title>Safety and efficacy of a prescription digital therapeutic as an adjunct to buprenorphine for treatment of opioid use disorder</article-title><source>Curr Med Res Opin</source><year>2021</year><volume>37</volume><issue>2</issue><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1080/03007995.2020.1846022</pub-id><pub-id pub-id-type="pmid">33140994</pub-id><pub-id pub-id-type="pmcid">PMC8666102</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence</article-title><source>J Consult Clin Psychol</source><year>2014</year><volume>82</volume><issue>6</issue><fpage>964</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1037/a0037496</pub-id><pub-id pub-id-type="pmid">25090043</pub-id><pub-id pub-id-type="pmcid">PMC4244262</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>P</given-names></name><etal/></person-group><article-title>Supporting continuity of care between prison and the community for women in prison: a medical record review</article-title><source>Aust Health Rev</source><year>2017</year><volume>41</volume><issue>3</issue><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1071/AH16007</pub-id><pub-id pub-id-type="pmid">27467100</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curtis</surname><given-names>M</given-names></name><etal/></person-group><article-title>Non-fatal opioid overdose after release from prison among men who injected drugs prior to their imprisonment: a prospective data linkage study</article-title><source>Med J Aust</source><year>2022</year><volume>218</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.5694/mja2.51774</pub-id><pub-id pub-id-type="pmid">36344250</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Votaw</surname><given-names>VR</given-names></name><etal/></person-group><article-title>The epidemiology of benzodiazepine misuse: a systematic review</article-title><source>Drug Alcohol Depend</source><year>2019</year><volume>200</volume><fpage>95</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2019.02.033</pub-id><pub-id pub-id-type="pmid">31121495</pub-id><pub-id pub-id-type="pmcid">PMC6639084</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Periods of altered risk for non-fatal drug overdose: a self-controlled case series</article-title><source>Lancet Public Health</source><year>2021</year><volume>6</volume><issue>4</issue><fpage>e249</fpage><lpage>e259</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(21)00007-4</pub-id><pub-id pub-id-type="pmid">33773635</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evoy</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Abuse and misuse of pregabalin and gabapentin: a systematic review update</article-title><source>Drugs</source><year>2021</year><volume>81</volume><issue>1</issue><fpage>125</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1007/s40265-020-01432-7</pub-id><pub-id pub-id-type="pmid">33215352</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomes</surname><given-names>T</given-names></name><etal/></person-group><article-title>Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study</article-title><source>PLoS Med</source><year>2017</year><volume>14</volume><issue>10</issue><fpage>e1002396</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1002396</pub-id><pub-id pub-id-type="pmid">28972983</pub-id><pub-id pub-id-type="pmcid">PMC5626029</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santo</surname><given-names>T</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis</article-title><source>JAMA Psychiat</source><year>2021</year><volume>78</volume><issue>9</issue><fpage>979</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2021.0976</pub-id><pub-id pub-id-type="pmcid">PMC8173472</pub-id><pub-id pub-id-type="pmid">34076676</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bird</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release</article-title><source>Addiction</source><year>2015</year><volume>110</volume><issue>10</issue><fpage>1617</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1111/add.12969</pub-id><pub-id pub-id-type="pmid">25940815</pub-id><pub-id pub-id-type="pmcid">PMC4744745</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>